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Riassunto 
 
In questo lavoro di tesi ci si è occupati dell’espressione, della purificazione e della 
cristallizzazione di tre enzimi (bile acid CoA:amino acid N-acyltransferase, 
BAAT; farnesyl cysteine-carboxyl methyltransferase, Ste14; e stearoyl-CoA 
desaturase, SCD) con lo scopo finale di determinarne la struttura tridimensionale 
mediante analisi di diffrazione di raggi X. 
I cDNA delle proteine in questione sono stati clonati in vettori per l’espressione in 
sistemi eterologhi. Le scelta del sistema di espressione opportuno per la 
produzione su larga scala è stata condotta dopo una valutazione della resa, della 
stabilità ed integrità del prodotto proteico. 
 
La proteina BAAT umana è stata espressa utilizzando il sistema procariotico 
E.coli. La proteina ricombinante è stata purificata tramite due cromatografie di 
affinità al nichel e gel filtrazione. L’integrità del campione ottenuto è stata 
controllata attraverso spettrometria di massa e l’omogeneità mediante DLS. E’ 
stata condotta anche una valutazione dell’attività enzimatica verificando la 
presenza dei prodotti mediante spettrometria di massa. Oltre alla proteina wild 
type è stato prodotto il mutante privo di attività enzimatica (C235A) per procedere 
con le prove di cristallizzazione in presenza del substrato. I campioni ottenuti si 
presentano sufficientemente puri, stabili ed omogenei per allestire le prove di 
cristallizzazione. Le prove di cristallizzazione hanno dato esito positivo con la 
proteina mutata, anche se i cristalli fino ad ora ottenuti non sono idonei per gli 
esperimenti di diffrazione di raggi X. 
La proteina di membrana Ste14 di C.glabrata è stata individuata come buon 
candidato per la produzione su larga scala al fine di condurre studi strutturali 
attraverso l’utilizzo di un sistema high-throughput pubblicato da Drew et al., 
2008. Il sistema prevede l’espressione eterologa in S. cerevisiae; la proteina di 
interesse viene prodotta in fusione alla GFP permettendo la valutazione del livello 
di espressione e la stabilità nei diversi detergenti attraverso misure di fluorescenza 
sull’estratto cellulare. L’enzima è stato purificato attraverso due cromatografie di 
affinità al nichel e gel filtrazione in presenza sia del detergente DDM sia del 
detergente LDAO. Il profilo della gel filtrazione suggerisce che il campione è 
  
‘monodisperso’ e quindi adeguato per l’allestimento di prove di cristallizzazione. 
Ad oggi non sono però stati ottenuti cristalli adatti ad esperimenti di diffrazione. 
E’ stato infine messo appunto un protocollo di espressione e purificazione per 
l’enzima transmembrana umano SCD. La proteina ricombinante è stata espressa 
in cellule di insetto e purificata in presenza del detergente DDM attraverso IMAC. 
La resa e la purezza del prodotto proteico ad oggi non è ancora ottimale ma la 
quantità di enzima è sufficiente per allestire prove di cristallizzazione e per 
condurre studi biochimici e strutturali. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Abstract 
 
This thesis work was aimed at the expression, purification and crystallization of 
three human proteins (bile acid CoA:amino acid N-acyltransferase, BAAT; 
farnesyl cysteine-carboxyl methyltransferase, Ste14; and stearoyl-CoA desaturase, 
SCD) in order to determine their three-dimensional structure using X-ray 
crystallography. 
The cDNA sequences were cloned into specific vectors for overexpression in 
heterologous systems. The choice of the best expression system was made 
considering the protein yield, stability and integrity before scaling up. 
 
Human BAAT was expressed in E.coli. The recombinant protein was purified by 
IMAC, reverse IMAC and gel filtration. The integrity of the sample was assessed 
by mass spectrometry and its homogeneity using DLS. The enzymatic activity 
was controlled verifying the presence of the products by mass spectrometry. In 
addition to the wild type protein, the catalytic mutant (C235A) was cloned and 
expressed to carry out crystallization trials in the presence of the substrate. The 
samples obtained are sufficiently pure, stable and homogeneous to set up 
crystallization trials. Crystals were obtained only with the mutant but they are not 
sufficiently ordered for X-ray diffraction experiments. 
Using the high-throughput system published by Drew et al., 2008, the membrane 
protein Ste14 from C.glabrata was selected as a good candidate for a large scale 
production in order to conduct structural studies. The system uses S.cerevisiae to 
overexpress membrane proteins; the protein of interest is cloned into a GFP-
fusion vector allowing to estimate the expression level and the stability in several 
detergents by measuring fluorescence directly in cell extracts. The enzyme was 
purified by IMAC, reverse IMAC and gel filtration in the presence of the 
detergents DDM and LDAO. The gel filtration profile indicates that the sample is 
‘monodisperse’ and hence adequate to set crystallization trials. Up to now no 
suitable crystals were obtained.  
Finally, a protocol for the expression and purification of the human membrane 
enzyme SCD was developed. The recombinant protein was expressed in insect 
cells and purified in the presence of the detergent DDM by IMAC. Until now the 
  
yield and the purity obtained are not optimal but a sufficient quantity of the 
enzyme can be extracted to carry out crystallization trials aimed at structural and 
biochemical studies. 
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I. Protein X-ray crystallography 
 
Protein X-ray crystallography is a powerful technique for obtaining atomic 
structural information. In the last decade this technique has found renewed interest 
since the genomes of humans and other organism were sequenced. This enabled 
the birth of high throughput crystallographic platforms aimed at solving the 
structures of all the encoded proteins, even in the absence of functional 
characterisations. 
 
Determining the 3D structure of biological macromolecules by X-ray 
crystallography involves several steps including cloning, expression, purification, 
and crystallisation of the target molecule, acquiring diffraction data, phasing the 
data, model building and refinement. However, the preparation of protein crystals 
remains the main bottleneck for protein crystallography, especially in the case of 
membrane proteins. 
 
I.I. Protein crystallization 
 
A battery of different experimental setups and strategies exist for attempting to 
crystallize proteins. The starting point for crystallization is to obtain pure protein 
that is highly concentrated in a water-based buffer solution. The procedure for 
crystallising proteins involves disolving the protein in a mixture of precipitant 
agents, such as organic solvents (e.g., PEG, MPD), highly concentrated salt 
solutions (e.g., ammonium sulphate or sodium malonate), or combinations of 
both. In these conditions the solubility of the proteins is reduced resulting in the 
formation of an amorphous protein precipitate. However if the appropriate 
conditions are selected so that specific attractive interactions can occur between 
the protein molecules, this can lead to protein crystallization. The crystallization 
process can be differentiated into two steps: (1) the nucleation process and (2) 
crystal growth. Under the correctly selected conditions, crystal nucleation and 
growth can be achieved within the supersaturated regions of the phase diagram. 
Nucleation is the process by which molecules or non crystalline aggregates which 
are free in solution come together in such a way as to produce a 
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thermodynamically stable aggregate with a repeating lattice. The nucleation range 
is also called the labile zone, while the growth range is known as the metastable 
zone. For crystal nucleation to occur, the experimenter must push the protein 
solution into the labile zone, which is also the region where fast growth of crystal 
nuclei occurs. This means that for a successful experiment the protein/precipitant 
mixture must approach the nucleation zone very slowly so that the developing 
nuclei have enough time to growth. The transition from a stable solution to a 
supersaturated solution can be achieved by adjusting the position of the 
protein/precipitant mixture in the example phase diagram (Fig.1.1).  
 
 
 
Fig.1.1. A schematic phase diagram showing the solubility of a protein in solution as a 
function of the concentration of the precipitant present. 
 
These experiments are based on trial-and-error, and the selected precipitants, their 
concentration, and the pH range are selected based on previous crystallisation 
successes. In one of such screening experiments, hundreds of conditions are 
tested. The crystallisation conditions are screened for promising results, such as 
very small crystals or crystalline precipitates, that can guide further crystallization 
rounds. Null results also provide useful information since they suggest that the 
protein concentration should be increased. A screening of nearly random 
conditions is required due to uncertainty in the effects of agents like ions, 
temperature, and pH on protein crystal growth (McPherson, 1990). 
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A. Bile Acid Coenzyme A:Amino Acid N-Acyltransferase  
 
A.1.1. Bile Acids 
 
Cells utilize several enzymatic mechanisms to clear the excess of cholesterol. The 
major pathway, accounting for approximately 90% of cholesterol breakdown, is 
the enzymatic conversion of cholesterol into bile acids by enzymes in the liver. 
The conversion is known to involve multiple hydroxylations of the ring structures 
and the oxidation and shortening of the side chain of cholesterol to produce a C24 
bile acid; but the precise number of steps, the identities of the enzymes involved, 
and the mechanisms by which the pathway is regulated are currently largely 
unknown (Russell, 2009). 
Bile acids are amphipathic molecules, which contain a sterol nucleus with 
hydroxyl groups and a side chain that terminates in a carboxyl group. Their 
amphipathic nature is essential to solubilize dietary lipids, which subsequently 
promotes their absorption in the digestive tract.  
 
 
 
Fig.1.2. Structure of selected bile acids (Houten et al., 2006). 
 
Bile acids that are synthesized from cholesterol in the hepatocyte are termed 
primary bile acids. Bile acids that are formed by bacterial modification of primary 
bile acids are termed secondary bile acids. The principal bile acids include in 
humans the primary bile acids cholic acid (CA) and chenodeoxycholic acid 
(CDCA), their glycine and taurine conjugates, and the secondary bile acids 
deoxycholic acid and lithocholic acid. In mice, CDCA is efficiently converted into 
muricholic acid (Fig.1.2). 
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Most of the bile acids are present within the enterohepatic organs. Usually bile 
acids are stored in the gallbladder; however, when a meal is ingested, they flow 
into the duodenum and intestine. Afterward they are efficiently (95%) reabsorbed 
by passive diffusion and active transport in the terminal ileum, and transported 
back to the liver via the portal vein. In the liver, bile acids are taken up at the 
basolateral (sinusoidal) membrane and exported again at the apical (canalicular) 
membrane of the hepatocytes into the bile canaliculus (transhepatic bile acid flux). 
This completes their enterohepatic circulation. Each bile acid molecule may 
complete 4–12 cycles between the liver and intestine per day. Owing to this 
efficient recirculation, only a small amount of the bile acid pool size is derived 
from de novo biosynthesis (Fig.1.3). 
 
 
 
Fig.1.3. Schematic depiction of the enterohepatic circulation of bile acids. 
 
Before the excretion of bile by the liver bile acids have to be conjugated to an 
amino acid. In normal bile, bile acids conjugated with glycine and taurine are the 
major solutes and unconjugated bile acids are almost nondetectable. Conjugated 
bile acids are less toxic and are more efficient promoters of intestinal absorption 
of dietary lipids than the unconjugated molecules (Solaas et al., 2000). 
It has also become clear that bile acids besides their roles in dietary lipid 
absorption and cholesterol homeostasis, are also signaling molecules. Three major 
signaling mechanisms have been identified. Bile acids activate mitogen-activated 
protein kinase (MAPK) pathways, are ligands for the G-protein-coupled receptor 
(GPCR) TGR5, and activate nuclear hormone receptors such as farnesoid X 
receptor a (FXRa; NR1H4)(Houten et al., 2006; Chiang, 2002). 
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A.1.1.1. Bile acid biosynthesis 
 
Cholesterol is converted into bile acids via multiple pathways which involve 
many different enzymes (Fig.1.4). Many of these enzymes are predominantly 
expressed in the liver and are localized in several different subcellular 
compartments. 
In the classic pathway, bile acid biosynthesis begins with the conversion of 
cholesterol into 7α-hydroxycholesterol by cholesterol 7α-hydroxylase (CYP7A1). 
This is a microsomal cytochrome P450 enzyme localized exclusively in the liver. 
Its expression is highly regulated and shows a strong diurnal rhythm. The classic 
pathway involving CYP7A1 is the major pathway in bile acid biosynthesis 
because its contribution to total bile acid synthesis is 90% in humans and 75% in 
mice.  
In the acidic pathway, oxysterols rather than cholesterol serve as substrates for 7α-
hydroxylation. Sterol 27-hydroxylase, a mitochondrial cytochrome P450 
(CYP27A1), forms predominantly 27-hydroxycholesterol but can also 
hydroxylate cholesterol at carbons 24 and 25. Alternatively, 24- and 25-
hydroxycholesterol are also the product of separate cholesterol 24- and 25-
hydroxylases. To be converted into bile acids, these oxysterols must undergo 7α- 
hydroxylation. Oxysterol 7α-hydroxylase (CYP7B1) catalyzes the conversion of 
27-hydroxycholesterol and 25 hydroxycholesterol, and is highly expressed in 
liver. The CYP39A1 oxysterol 7α-hydroxylas acts on 24-hydroxycholesterol. The 
acidic pathway is responsible for the remaining bile acid synthesis (10% in 
humans and 25% in mice).  
The next step in the ring structure modification involves isomerization of the 
double bond from the 5 to the 4 position and the oxidation of the 3β-hydroxyl-
group to a 3-oxo-group. This step is catalyzed by the microsomal 3β-hydroxy-∆5-
C27-steroid oxidoreductase (HSD3B7), which can only handle 7α-hydroxylated 
intermediates derived from both cholesterol and oxysterols. At this point in the 
biosynthesis pathway, the intermediates can be modified by sterol 12α-
hydroxylase (CYP8B1), and this will decide the fate of the produced bile acid. If 
the reaction is catalyzed by CYP8B1, another microsomal cytochrome P450, the 
final product will be cholic acid, if not either chenodeoxycholic acid (in humans) 
or muricholic acid (in mice) will be formed. 
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Subsequently, the products of HSD3B7, whether or not 12α-hydroxylated, are 
subject to reduction of the double bond by the enzyme ∆4-3-oxosteroid 5β-
reductase (AKR1D1), which is a cytosolic enzyme. The final step of the ring 
modifications involves reduction of the 3-oxo-group to an alcohol-group and is 
catalyzed by 3α-hydroxysteroid dehydrogenase (AKR1C4). 
 
 
 
Fig.1.4. Enzymes of bile acids synthesis. The 16 enzymes involved and the 17 reactions are 
shown. Mutations causing human disease have been identified in the nine enzymes that are 
boxed in blue. The structure of cholesterol and a generic conjugated bile salt are shown. R= 
OH or H; X= glycine or taurine (Russell, 2009). 
 
After the ring modifications, the sterol side chain is oxidized, activated and 
shortened by cleaving off propionyl-CoA. The first steps of this process are 
catalyzed by CYP27A1, which is the same mitochondrial enzyme that can initiate 
bile acid biosynthesis through formation of 27-hydroxycholesterol. The enzyme 
introduces a hydroxyl-group at carbon 27 and then oxidizes this group first to an 
aldehyde and then to a carboxylic acid. The products of this reaction are the bile 
acid intermediates 3α,7α-dihydroxycholestanoic acid (DHCA) and 3α,7α,12α-
trihydroxycholestanoic acid (THCA), which subsequently have to be activated to 
their CoA-ester. Two enzymes have been identified which can perform this 
reaction. The first is the very long-chain acyl-CoA synthetase (VLCS, encoded by 
SLC27A2) localized at the endoplasmic reticulum and in the peroxisome, and the 
second is bile acyl-CoA synthetase (BACS, also called very long-chain acyl-CoA 
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synthetase homolog 2, encoded by SLC27A5) exclusively localized at the 
endoplasmic reticulum. BACS, which is only present in liver, also displays 
activity towards C24-bile acids and is thought to be involved in the activation of 
bile acids which return to the liver via the enterohepatic circulation after 
deconjugation in the small intestine. It is unclear which of the two synthetases 
capable of activating C27-bile acids is responsible in vivo for the CoA-ester 
formation of DHCA and THCA, and whether this occurs at the endoplasmic 
reticulum or in the peroxisome (Russell, 2003; Russell, 2009).  
 
A.1.1.1.1. Peroxisomal steps in bile acid biosynthesis 
 
The first peroxisomal enzyme required for the conversion of DHC-CoA and THC-
CoA to chenodeoxycholoyl-CoA (CDCCoA) and choloyl-CoA (CA-CoA), 
respectively, is α-methylacyl-CoA racemase (AMACR). Its activity is necessary 
for this conversion, because only (25R)-stereoisomers are formed by CYP27A1, 
whereas the peroxisomal β-oxidation system can only handle (25S)-isomers. 
Thus, AMACR racemizes (25R)-DHC-CoA and (25R)-THC-CoA to their 
respective (S)-isomers, allowing subsequent β-oxidation of these substrates. In 
mouse and rat, THC-CoA oxidase (encoded by Acox2) oxidizes the CoA-esters of 
the C27-bile acid intermediates. Its ortholog in humans is the branched chain acyl-
CoA oxidase (BCOX, encoded by ACOX2), which is involved in the oxidation of 
the C27-bile acid intermediates and of pristanoyl-CoA that has a methyl-group at 
the 2 position just like the side-chains of DHCA and THCA. The acyl-CoA 
oxidase desaturates (25S)-THC-CoA to 3α,7α,12α- trihydroxy-5β-cholest-24-en-
26-oyl-CoA (24(E)-ene-THCCoA). The two subsequent reactions are catalyzed 
by D-bifunctional protein (DBP, also called multifunctional protein 2, 
multifunctional enzyme II, or D-peroxisomal bifunctional enzyme, encoded by 
HSD17B4). DBP consists of multiple functional units and is a stereospecific 
enzyme. Its hydratase unit converts 24(E)-ene-THC-CoA exclusively into 
(24R,25R)-3α,7α,12α,24-tetrahydroxy-5β-cholestanoyl-CoA (24-OH-THC-CoA), 
which is converted into 3α,7α,12α-trihydroxy-24-keto-5β-cholestanoyl-CoA (24-
keto-THC-CoA) by the dehydrogenase unit of DBP. Finally, sterol carrier protein 
X (SCPx) cleaves 24-keto-THC-CoA to CA-CoA and propionyl-CoA. The β-
oxidation of the side-chain of DHC-CoA is analogous to that of THC-CoA. 
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The last step in bile acid biosynthesis involves conjugation of CDC-CoA and CA-
CoA with an amino acid. This reaction is catalyzed by the bile acyl-CoA: amino 
acid N-acyltransferase (BAAT), which is predominantly expressed in liver and is 
localized in peroxisomes and the cytosol. This dual localization suggests that the 
peroxisomal BAAT is responsible for conjugation of the newly formed primary 
bile acids within the peroxisome, whereas the cytosolic BAAT will be involved in 
reconjugation of the recycled primary and secondary bile acids that have been 
deconjugated in the gut. After conjugation, bile acids have to be transported  from 
the peroxisome by an as yet unidentified transporter and are then excreted from 
the hepatocyte into the bile (Russell, 2003; Russell, 2009; Ferdinandusse, 2006). 
 
A.1.1.1.2. Bile acid conjugation 
 
C24 bile acids are conjugated with either glycine or taurine. Conjugation with 
taurine results in the formation of a molecule that is fully ionized and highly 
soluble at the small intestine pH during digestion (pH 6-7). In addition, 
conjugation results in a molecule that is always negatively charged and therefore 
towards which cell membranes are impermeable. Moreover, the bile salt molecule 
is too large to diffuse through the paracellular junctions of the biliary tract and 
small intestine. Impermeability in the apical membrane of cholangiocytes and 
enterocytes and the paracellular junctions between these cells is a key factor in 
promoting the high intraluminal concentration of conjugated bile acids in the 
biliary tract and small intestine. Conjugation with glycine converts a weak acid 
(pKa of 5) to a slightly stronger acid (pKa of 4). The result is increased solubility 
and ionization at the pH conditions prevailing during digestion. In man, intubation 
studies have shown that most glycine conjugated bile acids are in solution during 
digestion (Hofmann and Hagey, 2008). 
 
A.1.2. Bile acid coenzyme A:amino acid N-acyltransferase  
 
Bile acid coenzyme A:amino acid N-acytransferase (BAAT) is the enzyme 
involved in the addition of an amino acid, usually glycine or taurine, in amide 
linkage to carbon 24 (Fig.1.5). The N-acyltransferase is a remarkably efficient 
enzyme as more than 98% of bile acids excreted from the liver are amidated.  
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Fig.1.5. Conjugation of bile acids. The chemical modifications introduced by the enzyme are 
indicated in red on the products of the reaction. Cumulative changes to sterol intermediates 
are indicated in green (Russell, 2003).  
 
BAAT activities have been identified in numerous species, including fish, 
seabream, dog, bovine, domestic fowl, rat, mouse and human. BAAT activity has 
been characterized not only in the liver of these animals, but activity has also been 
observed in the rat kidney (Shonsey et al., 2005). 
Sequence similarity searches have detected significant similarity of BAAT to 
dienelactone hydrolase and other α/β hydrolases of known structure. The α/β 
hydrolase fold is shared by several enzymes that apparently have diverged from a 
common ancestor. Despite their different catalytic functions, these enzymes all 
contain a conserved nucleophile- histidine-acid catalytic triad with the histidine 
being a completely conserved amino acid and the nucleophile and acid loops 
accommodating more than one type of amino acid. Amino acid sequence 
alignments also revealed that hBAAT and other BAATs have high homology 
(above or equal to 40%) with peroxisomal, mitochondrial, and cytosolic long 
chain acyl-CoA thioesterases or acyl-CoA thioesterases.  
Using mutation analysis it was established that hBAAT utilizes a catalytic triad 
composed of Cys-235, His-362, and Asp-328 with Cys-235 as the nucleophile. 
Catalysis in hBAAT may follow the classical charge-relay mechanism shared by 
serine proteases and thioesterases proposed by Pazirandeh et al.,1991. The 
reaction involves five steps: 1) nucleophilic attack of Cys-235 on the carbonyl 
carbon of bile acid-CoA substrate to form a tetrahedral intermediate; 2) 
decomposition of the tetrahedral intermediate to the acyl-enzyme intermediate 
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(CoA is cleaved from bile acid-CoA); 3) amino acid (glycine or taurine) attack on 
the carbonyl carbon of the acyl-enzyme intermediate; 4) formation of the second 
tetrahedral intermediate; and 5) generation of the bile acid-amino acid conjugate 
and recovery of the active enzyme (Sfakianos et al., 2002)(Fig.1.6). 
 
 
 
Fig.1.6. The catalytic mechanism of hBAAT (Sfakianos et al., 2002). 
 
In recent evolutionary history (last 25 million years), conjugation with glycine has 
appeared in several branches of the mammalian kingdom. Interestingly, most 
monkeys in the New World are exclusively taurine conjugators, whereas Old 
World primates conjugate with both amino acids. Some mammals (pigs and 
rabbits) are principally glycine conjugators. Mouse BAAT is only active with 
taurine (Falany et al., 1997), but humans can conjugate bile acids with both 
taurine and glycine. The ratio of glycine to taurine conjugated bile acids in 
humans is solely dependent on the relative abundance of the two amino acids.  
Several procedures have been described for the purification of BAAT from rat 
liver, human liver, domestic fowl liver and bovine liver. Kinetic studies about 
hBAAT revealed apparent Km values for taurine and glycine of 1.1 and 5.8 mM, 
respectively, with corresponding Vmax, values of 0.33, 0.19, and 0.77 
pmol/min/mg protein (Johnson et al., 1991).  
The cDNA encoding human BAAT was isolated and characterized by Falany et 
al., 1994. Sequencing and expression of the hBAAT cDNA validated the identity 
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of the purified BAAT. The Km values for glycine (5.6±0.1 mM) and taurine 
(1.8±0.1 mM) in the formation of cholic acid conjugates catalyzed by the 
expressed purified enzyme were very similar to the values (5.8 and 1.1 mM, 
respectively) obtained with pure liver hBAAT. 
Expression of the BAAT enzyme is induced by the farnesoid X receptor (FXR, 
NR1H4). FXR regulates bile acid and lipid homeostasis by acting as an 
intracellular bile acid-sensing transcription factor. Analysis of the human BAAT 
gene revealed the presence of functional response elements in the intronic region 
between exon 1 and 2. The response elements resemble the consensus FXR 
binding site consisting of two nuclear receptor half-sites organized as an inverted 
repeat and separated by a single nucleotide (IR-1). 
These response elements directly bind FXR/retinoid X receptor (RXR) 
heterodimers and confer the activity of FXR ligands in transient transfection 
experiments. Further mutational analysis confirms that the IR-1 sequence of the 
BAAT gene mediates transactivation by FXR/RXR heterodimers. In addition, rats 
treated with the synthetic FXR ligand GW4064 clearly show increased transcript 
levels of BAAT mRNA (Pircher et al., 2003).  
hBAAT and rBAAT have been reported to reside in peroxisomes with variable 
amounts present in the cytosol. Consequently, it has been proposed that 
peroxisomal BAAT is required for conjugation of de novo synthesized bile salts, 
whereas the cytosolic pool of BAAT is required for reconjugation of deconjugated 
bile salts returning from the intestine (Solaas et al., 2000; He et al., 2003). Some 
studies affirm that the majority of BAAT activity resides in the cytosol and 
approximately 15% of BAAT activity is present in the peroxisomal matrix (Styles 
et al., 2007); others suggest that the enzyme localizes specifically to peroxisomes 
(Pellicoro et al., 2007). Recently using photobleaching techniques it was found 
that GFP tagged BAAT was exclusively localized in the cytosol (Buch et al., 
2009). hBAAT and rBAAT contain an established variant of PTS-1 (C-terminal 
SLK) at their C-termini, SQL. This signal is recognized by the cytosolic PTS-1 
receptor Pex5p, which is responsible for sorting to the peroxisome. Probably the 
cytosolic localization is due to its carboxy terminal non-consensus peroxisomal 
targeting signal since mutation of the SQL to SKL resulted in BAAT being 
efficiently imported into peroxisomes. 
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A.1.2.1. BAAT deficiency 
 
Four members of two Amish families have been reported with a homozygous 
mutation in the BAAT gene. The patients had increased serum bile acid levels and 
the bile acids in serum were unconjugated. Because unconjugated bile acids are 
not efficiently excreted in the bile, the bile acid concentrations in the intestine 
were hypothesized to be very low resulting in fat malabsorption, failure to thrive 
and a vitamin-K dependent coagulopathy. These clinical features correspond to a 
genetic syndrome known as Familial hypercholanemia (FHCA). Genomic 
sequencing of exons and exon-intron boundaries of BAAT identified a Met76-to-
Val (M76V) mutation (Carlton et al., 2003). 
Another boy had been described previously with no glyco- or tauro-conjugated 
C24-bile acids,  but at that time a specific BAAT deficiency had not been 
established with certainty. This patient had a similar clinical presentation with 
cholestasis associated with high serum and urine bile acid levels and low levels of 
fat-soluble vitamins. 
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B. Two membrane enzymes: Farnesyl Cysteine-Carboxyl 
Methyltransferase and Stearoyl-CoA 9-Desaturase 
 
B.1.1. Membrane proteins 
 
Membrane proteins continue to be among the most challenging targets in 
structural biology. All cells and organelles are contained within a hydrophobic 
lipid bilayer. Membrane proteins are involved in a wide variety of biological 
processes including photosynthesis, respiration, signal transduction, molecular 
transport and catalysis. These proteins represent between 20 and 30% of the 
proteomes of most organisms (Krogh et al., 2001) and more than 40% of drug 
targets (Overington et al., 2006) and yet very few structures of these molecules 
have been solved by X-ray crystallography or NMR. The first membrane protein 
structure was published in 1985 (Deisenhofer et al., 1985) and since then the 
number has increased slowly but steadily (White, 2009) (Fig.1.7).  
 
 
 
Fig.1.7. Growth of unique membrane protein structures deposited in the PDB. In blue, the 
number of structures of prokaryotic membrane proteins, and in yellow, the total number of 
eukaryotic structures. Both monotopic and multispanning proteins are included. For this 
study proteins are regarded as unique if they come from the same family but for different 
species (Carpenter et al., 2008).  
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To date there are over 50000 entries in the Protein Data Bank (PDB) repository of 
protein structures, but less than 1% of these entries represent membrane proteins. 
Of the 368 membrane protein structures in the ‘Membrane proteins of known 3D 
structure’ database (http://blanco.biomol.uci.edu/Membrane_Proteins_xtal.html), 
148 belong to unique proteins. Eukaryotic membrane proteins are particularly 
under-represented, with only 39 examples (Carpenter et al., 2008). 
 
In general membrane proteins occur in a wide distribution of sizes and shapes and 
can exist as monomers or in homo- hetero-oligomeric complexes. These proteins 
may also be completely buried into the bilayer or have large extra membranous 
domains.  
Membrane proteins are typically classified in two ways: according to their 
interaction with the lipid bilayer (peripheral/integral membranes proteins) or 
according to the mechanism by which the proteins assemble into the membranes 
(costitutive/non-costitutive membrane proteins).  
Proteins that bind or hardly penetrate the membrane surface without spanning it 
are referred to as monotopic or peripheral membrane proteins. These proteins can 
often be released from the membrane by an increase in ionic strength. Peripheral 
membrane proteins associate with lipid bilayers using different structural motifs 
such as amphipathic α-helices that orient parallel to the membrane plane, 
hydrophobic loops, or by the formation of covalent bonds to membrane lipids 
(lipidation). Integral membrane proteins span the bilayer once or several times. 
These proteins can only be released from the membrane by bilayer disruption with 
detergents. Integral transmembrane proteins can be divided into two classes 
according to the secondary structure adopted by the bilayer-embedded regions: α-
helical bundles (e.g., rhodopsin) and β-barrels (e.g., porins).  
Costitutive membrane proteins are assembled through a complex 
translocation/insertion process that involves synthesis by ribosomes that 
transiently attach to translocon proteins embedded in the membrane. Non-
costitutive membrane proteins, which are generally pore forming toxins, exist in 
at least three different forms: water-soluble, bound to the membrane surface and 
with membrane embedded regions. In contrast to costitutive integral proteins, 
non-costitutive proteins spontaneously partition into the membrane without 
translocon complexes.  
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B.1.1.1. Structural biology of membrane proteins 
 
Determining the atomic structure of a membrane protein is a very challenging 
task. The main difficulty is that large quantities of homogeneous, aqueous-soluble 
samples are required for most structural biology techniques. Thus, membrane 
proteins must be isolated from the lipid environment by solubilization with 
detergents. The use of detergents often causes protein instability, loss of activity, 
and denaturation.  
In addition, membrane proteins are difficult to express and purify, often 
precipitate upon concentration, and are difficult to crystallize since detergents may 
interfere with the formation of protein-protein contacts. A variety of approaches 
have been used to crystallize membrane proteins. Diffraction quality crystals have 
been mainly obtained by the vapour diffusion method from detergent solubilised 
proteins (Iwata, 2003). In some cases these preparations have been aided by co-
crystallization with Fv or Fab fragments, which provide additional hydrophilic 
regions for the formation of crystal contacts (Hunte and Michel, 2002). A more 
recent, but less popular approach to crystallizing membrane proteins is the meso 
crystallization method, which is based on the lipidic cubic phase (LCP) medium 
or mesophase (Caffrey, 2000; Caffrey, 2003).  
 
B.1.1.2. Large-scale production of membrane proteins 
 
Membrane proteins of known structure have been purified from natural sources, 
produced recombinantly or, in the case of short peptides, synthesised chemically. 
They have been successfully expressed in the bacteria Escherichia coli and 
Lactococcus lactis, the yeasts Pichia pastoris and Saccharomyces cerevisiae, in 
insect cells and in mammalian cell lines (Junge et al., 2008).  
Despite major efforts, the expression of eukaryotic membrane proteins still 
represents a major bottleneck in the production of proteins for structural studies. 
Although there are several examples in the literature of successful expression of 
eukaryotic membrane proteins in E. coli (Grisshammer et al., 2005; Sarramegna et 
al., 2003) there is to date only one high resolution structure of an eukaryotic 
membrane protein expressed in E. coli (human 5-lipoxygenase-activating protein, 
Ferguson et al., 2007).  
Chapter 1                                                                                                                          Introduction 
- 17 - 
 
Thus, eukaryotic proteins are likely to require the use of eukaryotic systems for 
expression. Firstly, membrane proteins have to be targeted to the host cell 
membrane before they can fold correctly. Specific systems are required in the host 
cell such as the SRP-Sec61 system that inserts membrane proteins into the 
endoplasmic reticulum of eukaryotic cells. Secondly, membrane proteins are 
embedded in lipid, and the composition of these lipids varies among the systems. 
The nature of the lipids can affect the stability of the protein and consequently its 
likelihood of crystallisation. Thirdly eukaryotic proteins may undergo 
posttranslational modifications, such as glycosylation, and only higher eukaryotic 
cell lines provide the necessary machinery (Carpenter et al., 2008). 
A number of membrane proteins expressed in P.pastoris have yielded high 
resolution structures including the mammalian voltage-dependent potassium 
channel (Long et al., 2005), the plant aquaporin (Törnroth-Horsefield et al., 2006) 
and the human LTC4 synthase (Molina et al., 2007) and most recently the human 
ABC multidrug transporter, P-glycoprotein (Aller et al., 2009). S. cerevisae has 
been used to produce protein which ultimately yielded the high resolution 
structure of P-type proton pump from Arabidopsis thaliana (Pedersen et al., 2007) 
and diffracting crystals of rabbit Ca2+ATPase SERCA1a (Jidenko et al., 2005). 
Insect cell based expression systems have had spectacular successes for the 
production of GPCRs for structural studies, yielding three independent structures, 
the human adenosine A2A receptor (Jaakola et al., 2008), the turkey β1 adrenergic 
receptor (Warne et al., 2008) and the human β2-adrenergic receptor (Cherezov et 
al., 2007). In addition, insect cells were also used to produce the chicken voltage 
dependent acid sensing ion channel which subsequently was crystallized and the 
3D structure solved to 1.9 Å (Jasti et al., 2007). 
The majority of researchers working in the area of eukaryotic membrane protein 
structural determination use one of these three systems for protein production. 
Other systems are available including the Semliki Forest Virus mammalian cell 
expression system (Lundstrom, 2003) and an alternative bacterial system using 
the gram positive bacterium Lactococcus lactis (Kunji et al., 2005).  
Neither system has yet resulted in a high resolution structure but it is unclear 
whether this is due to inherent unsuitability of the systems for large scale 
production of eukaryotic membrane proteins for structural studies or to the fact 
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that these systems are not as extensively utilized as the yeast and insect cell 
systems.   
Not many major advances have been made in terms of expression of eukaryotic 
membrane proteins in the last 5-10 years or so, although some researchers are 
performing careful, rational optimization of the existing systems with a view to 
maximizing quality and quantity of the target proteins. One exception to this is the 
development of cell-free expression systems for the production of membrane 
proteins (Schwarz et al., 2008; Liguori et al., 2007). This type of approach 
involves in-vitro production of proteins outside intact cells from a DNA or mRNA 
template using a basic set of biological building blocks obtained from cell lysate. 
A wide range of cell lysates are available and it has been shown that those from 
eukaryotic sources, eg. rabbit reticulocytes, are capable of post-translational 
modifications suggesting these may be suitable for production of eukaryotic 
membrane proteins. By its very nature the system removes the problem of 
cytotoxicity and also simplifies protein isolation as the number of contaminant 
proteins is markedly reduced. A further advantage of this system is the high level 
of control a user has, in terms of modifying media components to both increase 
the stability of the expressed proteins (eg protease inhibitors, lipids, co-factors) 
and to efficiently label for analysis by NMR or X-ray crystallography. A major 
advantage for membrane proteins is that the expressed membrane proteins are 
maintained in a soluble state in detergent micelles post-translationally since there 
are no native membrane environments for insertion. There are many examples of 
functionally active prokaryotic and eukaryotic membrane proteins being produced 
in this system (Schwarz et al., 2008).  
As ever, work on  eukaryotic membrane proteins lags behind but efforts are 
currently underway to exploit this system effectively for structural studies. 
 
B.1.1.3. Membrane protein solubilisation 
 
Membrane proteins are extracted from the host cell membranes by the addition of 
detergents, which disrupt the membrane and cover the hydrophobic surface of the 
protein allowing their solubilization. The choice of the detergent is a crucial part 
of the purification process. A number of different detergents are usually tested and 
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the one that extracts the largest amount of soluble, active, homogeneous, stable 
protein is used in all the purification steps (Carpenter et al., 2008).  
Water solubility is provided by the hydrophilic portion of a detergent molecule. 
Based on the hydrophilic group, the detergents can be divided in ionic (cationic or 
anionic), nonionic, or zwitterionic. Ionic detergents, including sodium dodecyl 
sulfate (SDS), N-lauryl sarcosine, cetyltrimethylammoniumbromide (CTAB), and 
sodium cholate are effective in extracting proteins from the membrane. However, 
these detergents are harsh and tend to be denaturing because they efficiently 
disrupt both inter- and intra-molecular protein-protein interactions. SDS, for 
example, is commonly used as a membrane protein denaturant in quantitative 
protein unfolding/folding studies. Bile acid salts (i.e., sodium cholate, deoxycholic 
acid) are also ionic detergents; however, they tend to be milder than straight chain 
ionic detergents. Nonionic detergents, including maltosides, glucosides, and 
polyoxyethylene glycols are characterized by uncharged hydrophilic head groups. 
These detergents are mild and nondenaturing because they disrupt protein-lipid 
and lipid-lipid interactions rather than protein-protein interactions. Short chain 
(i.e., C7-C10) nonionic detergents are typically more deactivating than longer 
chain (i.e., C12-C14) nonionic detergents. A majority of detergents used in the 
purification and structural studies of membrane proteins (i.e., lauryl maltoside, 
octyl glucoside) are nonionic detergents. Zwitterionic detergents, including the 
Zwittergents®, Fos-Cholines®, CHAPS/CHAPSO, and amine oxides contain 
both a positive and negative charge in their hydrophilic head group. These 
compounds are electrically neutral like the nonionic detergents, but can often 
disrupt protein-protein interactions like the ionic detergents (Schimerlik, 2002; 
Iwata, 2003; Prive, 2007; Lin and Guidotti, 2009). 
 
B.1.2. Farnesyl cysteine-carboxyl methyltransferase 
 
In eukaryotic cells, a specific set of proteins are modified by C-terminal 
attachment of 15-carbon farnesyl groups or 20-carbon geranylgeranyl groups that 
function both as anchors for fixing proteins to membranes and as molecular 
handles for facilitating binding of these lipidated proteins to other proteins (Parish 
and Rando, 1996). Additional modification of these prenylated proteins includes 
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C-terminal proteolysis and methylation, and attachment of a 16-carbon palmitoyl 
group (Casey 1995; Casey and Seabra, 1996). Blocking protein prenylation is 
proving to be therapeutically useful for the treatment of certain cancers, infection 
by protozoan parasites and the rare genetic disease Hutchinson-Gilford progeria 
syndrome. 
 
B.1.2.1. Prenylation process 
 
Isoprenoids are lipids made up of five-carbon blocks, and they constitute one of 
the main classes of natural products. A subset of isoprenoids called prenyl groups 
are found on a variety of biological substances, including proteins. Prenylated 
proteins and peptides are found in most eukaryotes. They arise from the post-
translational attachment of 15-carbon farnesyl or 20-carbon geranylgeranyl groups 
to the C-terminal segment of proteins.  
 
 
 
Fig.1.8. Structures of the C termini of prenylated proteins. Farnesylated protein (left); 
geranylgeranylated protein (middle); doubly geranylgeranylated protein (right)(Gelb et al., 
2006).  
 
Fig.1.8 shows the structures of the C termini of prenylated proteins. Known 
farnesylated proteins include nuclear lamins A and B, which form a filamentous 
structural layer on the inner side of the nuclear membrane; the γ subunit of the 
heterotrimeric G protein transducin, which functions in visual signal transduction 
in the retina; all three isoforms of Ras GTP-binding proteins, which function in 
cellular growth regulation; the large-antigen component of the hepatitis δ virus; 
and yeast a-factor (Gelb et al., 2006). 
All farnesylated proteins contain a C-terminal sequence CAAX, where C is 
cysteine, A is usually but not necessarily an aliphatic amino acid and X is one of a 
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variety of amino acids. After attachment of the farnesyl group via a thioether 
linkage to the cysteine residue, the last three amino acids, AAX, are removed by a 
prenyl protein-specific endoprotease, and the α-carboxyl group of the newly 
exposed farnesylated cysteine is methylated by a prenyl protein–specific 
methyltransferase. Known geranylgeranylated proteins include the γ subunit of 
heterotrimeric G proteins that function at the plasma membrane, and many small 
GTP-binding proteins. The Rab subfamily of GTP-binding proteins contain a pair 
of geranylgeranyl groups on adjacent or nearly adjacent cysteines at the C 
terminus of the protein (Gelb et al., 2006). 
 
 
 
Fig.1.9. An overview of CAAX-protein processing. a) Proteins that contain a carboxy-
terminal CAAX motif are initially modified by the cytosolic CAAX prenyltranferases 
farnesyltransferase or geranylgeranyltransfersase-I. b) Following prenylation, the CAAX 
protein travels to the endoplasmic reticulum (ER), where the C-terminal three amino acids 
(AAX) are proteolytically removed by RCE1. c) The protein is then carboxyl methylated by 
isoprenylcysteine carboxyl methyltransferase (Icmt). d) Following methylation, fully 
processed CAAX proteins are directed to their appropriate cellular location, which is often 
the cytoplasmic surface of cell membranes (Winter-Vann and Casey, 2005). 
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Three distinct protein prenyltransferases that attach prenyl groups to proteins have 
been identified. Protein farnesyltransferase (PFT) transfers the farnesyl group 
from farnesyl diphosphate to the cysteine SH of the CAAX motif at the C 
terminus of proteins. Protein geranylgeranyltransferase type I (PGGT-I) catalyzes 
a similar reaction using geranylgeranyl diphosphate as the prenyl donor. Protein 
geranylgeranyltransferase type II (also known as Rab geranylgeranyltransferase) 
catalyzes the transfer of both geranylgeranyl groups from geranylgeranyl 
diphosphate to two cysteine SH groups at the C terminus of Rab proteins. Much is 
known about the structure and catalytic properties of these enzymes. All three are 
heterodimeric proteins that use active site-bound Zn2+ as a catalytic cofactor 
(Zhang et al., 2000; Long et al., 2002). The specificity rules that dictate which 
CAAX motifs are acted on by PFT, which are acted on by PGGT-I and which are 
not prenylated at all are not completely understood The X residue of CAAX is 
probably the most important element for differential recognition by PFT versus 
PGGT-I, but the AA portion of CAAX is also important (Reid et al., 2004). The 
postprenylation CAAX processing machinery includes the endoprotease Rce1 
(Ras converting enzyme I), which releases an intact AAX tripeptide from the 
newly prenylated CAAX protein, and isoprenylcysteine 
carboxylmethyltransferase (Icmt), which transfers a methyl group from S-
adenosylmethionine to the α-carboxyl group of the prenyl cysteine. The RCE1 
CAAX protease, is an integral membrane protein that resides in the endoplasmic 
reticulum. The catalytic mechanism of RCE1 does not allow this protein to be 
neatly categorized into any previously known enzyme class, but sequence and 
motif analysis has been used to argue that RCE1 is a metalloprotease. The final 
CAAX-directed processing step also takes place at the endoplasmic reticulum. 
Icmt was first identified in yeast, on the basis of its requirement for processing the 
a-factor mating pheromone and, like the endoproteases, is an integral membrane 
protein, which is unusual for a methyltransferase. Following modification by 
Icmt, the fully processed C terminus of a CAAX protein consists of a methyl-
esterified farnesyl or geranylgeranylcysteine. Similar to RCE1-mediated 
proteolysis, the methylation of CAAX proteins is essential for mouse 
development; mice lacking Icmt die by embryonic day (Winter-Vann and Casey, 
2005; Gelb et al., 2006) (Fig.1.9). 
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B.1.2.1.1. Therapeutic intervention based on protein prenylation 
 
Regardless of how the protein uses its modified cysteine residue, one aspect is 
very clear - the modifications are crucial for the biological activities of the 
proteins. For this reason, the CAAX proteins prenyltransferases have been the 
focus of drug-discovery programs for over a decade. For example, interest in 
understanding protein farnesylation for the purpose of cancer therapy grew out of 
the finding that one of the most common cancer-promoting elements in cells, the 
Ras proteins, require farnesylation to transform cells into tumors progenitors. 
Early preclinical studies showed that farnesyltransferase inhibitors (FTIs) had 
high efficacy and surprisingly low toxicity, and clinical trials of two such 
compounds have reached Phase III trials. Although these experimental agents 
have shown significant activity in several clinical trials, particularly in 
haematological cancers, the overall response rates in patients with solid tumours 
have been less successful than was initially hoped. One frequently cited 
possibility for this is the phenomenon known as ‘alternate prenylation’, which 
allows some FTase substrates to be modified by GGTase-I and thereby escape 
inhibition by FTIs (Winter-Vann and Casey, 2005). Following the discovery that 
RAS proteins are mislocalized in cells that lack the RCE1 protease or Icmt 
methyltransferase (Kim et al., 1999; Bergo et al., 2000), these post-prenylation-
processing steps have attracted attention as potential targets in oncogenesis, 
because even alternately prenylated forms of CAAX proteins would probably be 
sensitive to inhibition of both enzymes.  
 
B.1.2.2. Isoprenylcysteine carboxyl methyltransferase family 
 
Prenylation allows otherwise hydrophilic proteins to associate with cellular 
membranes, presumably by the insertion of the prenyl lipid into the phospholipid 
bilayer. Such an insertion would bring the α-carboxyl group of the prenylcysteine 
into proximity with the negatively charged head groups that are predominant 
among the phospholipids of the cytosolic leaflet of the plasma membrane. Methyl 
esterification removes the negative charge on the cysteine and thereby eliminates 
the electrostatic repulsion that would otherwise occur. Thus, carboxyl methylation 
of prenylproteins is believed to be a mechanism to increase their affinity for the 
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plasma membrane. Methyltransferases catalyze the transfer of a methyl group 
from methyl donors such as S-adenosylmethionine to various methyl acceptor 
substrates:  
 
S-adenosyl-L-methionine + protein C-terminal S-farnesyl-L-cysteine 
= 
S-adenosyl-L-homocysteine + protein C-terminal S-farnesyl-L-cysteine methyl ester. 
 
Ste14 from S.cerevisiae was the first member of the prenylcysteine protein 
carboxyl methyltransferase family to be cloned and sequenced (Sapperstein et al., 
1994). Subsequently, several homologues of Ste14 have been identified. These 
include S. pombe mam4p,  X. laevis mam4p, and the human homologue Icmt 
(Imai et al., 1997; Dai et al., 1998). In addition, database searches identified a 
mouse EST and two C. elegans open reading frames that have significant amino 
acid sequence homology to Ste14. There is strong conservation among these 
family members, with mam4p having the highest (44%) amino acid sequence 
identity to Ste14. The members of this family have similar hydropathy profiles 
and constitute one of the few subgroups of methyltransferases that contain 
multiple membrane spans. Most of the amino acid conservation between these 
family members occurs at their C-termini, suggesting that residues important for 
CAAX methyltransferase activity are located at the C-terminus. Like S. cerevisiae 
Ste14, the homologues S. pombe mam4p, Xenopus mam4p, and human Icmt have 
been shown to possess in vitro CAAX methyltransferase activity (Imai et al., 
1997; Dai et al., 1998). These CAAX methyltransferases are able to 
transcomplement other CAAX methyltransferase family members in vivo 
(Romano et al., 1998). Together these proteins form a novel family of protein 
prenylcysteine carboxyl methyltransferases. To date the only kinetic studies of an 
isoprenylcysteine methyltransferase activity were performed on the bovine 
methyltransferase in retinal rod outer segment membranes (Shi and Rando, 1992) 
and, most recently, on recombinant human Icmt (Baron and Casey, 2004). They 
have demonstrated that the kinetic mechanism of CAAX protein methylation by 
Icmt is an ordered sequential mechanism in which the S-adenosyl-L-methionine 
substrate associates first with the enzyme and the S-adenosyl-L-homocysteine 
product dissociates at the end.  
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B.1.2.1.1. Farnesyl cysteine-carboxyl methyltransferase from S.cerevisiae  
 
Ste14 is a 26 KDa, ER-multispanning enzyme. Ste14 contains no known protein 
motifs, and the residues involved in its function and localization have not been 
well identified. Romano and Michaelis, 2001 proposed that the protein contains 
six membrane spans, two of which forming a helical hairpin and has the majority 
of its hydrophylic regions located in the cytosol.  
 
 
Fig.1.10. A) Alignment of the C-terminal region of S. cerevisiae Ste14 and its homologues (S. 
pombe mam4p, X.laevis Xmam4p, 2 C. elegans open reading frames, a rat open reading 
frame, and human Icmt), open reading frames from Pseudomonas denitrificans, Bacillus 
subtilis, Mycobacterium tuberculosis, Ralstonia eutropha, Synechocystis sp, Archaeoglobus 
fulgidus, and Pyrococcus horikoshii, the S. cerevisiae lipid methyltransferases Pem1p and 
Pem2p, the sterol biosynthesis enzymes from S. cerevisiae Erg4p and Erg24p, and the human 
lamin B receptor, which is an Erg24p homologue. Black boxes denote amino acid identity 
and gray boxes denote amino acid similarity. The bar above the sequence denotes the 
putative membrane span of Ste14. B) Consensus sequence is based on the alignment shown 
in A. Only residues that are identical in ≥11 of the proteins in the alignment were scored as 
consensus residues; other residues are shown as an x. The hydrophobic region was 
determined by a hydropathy plot (Romano and Michealis, 2001). 
 
It was also shown that five out of six loss-of-function mutations obtained by 
random mutagenesis lie in residues that are conserved between Ste14 and its Icmt 
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homologues. In addition, by database search and sequence comparisons a C-
terminal region of Ste14 was identified that is conserved between the Icmt family 
of protein methyltransferases, two phospholipid methyltransferases and three 
sterol reductases. This region defines a consensus sequence that was designated 
the RHPxY-hyd-EE motif (Fig.1.10). Site-directed and random mutations indicate 
that residues in this region play a critical role in Ste14 function.  
Recently the topology of human Icmt was also mapped; Icmt traverses the ER 
membrane eight times (Wright et al., 2009) (Fig.1.11). Comparison of the 
structure of human Icmt with that of Ste14 reveals several striking features.  
 
 
 
 
Fig.1.11. A) Topology of Icmt deduced from data derived from the fluorescent probe and 
glycosylation reporter (Wright et al., 2009). Stars indicate sites that mapped to the cytosol, 
and asterisks indicate sites that mapped to the lumen of the ER. B) Topology of Ste14 of S. 
cerevisiae as described by Romano and Michaelis, 2001.  
 
First, the luminal loops of both enzymes are minimal, consistent with the fact that 
the catalytic face of the enzyme must be cytosolic since that is where the 
substrates are found. Second, the structure of human Icmt TM3-8 corresponds 
closely to that of Ste14, suggesting that all of the catalytic activity residues are in 
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the C-terminal portion of mammalian Icmt. Third, residues conserved between 
human Icmt and Ste14 occur both in the TM segments as well as in the 
cytoplasmic loops and the C-terminal cytoplasmic tail. Therefore, the conserved 
residues in the cytosolic loops and tail of the enzyme are likely to be involved in 
substrate binding and/or catalysis. The fourth, seventh, and eighth TM segments 
have clusters of conserved amino acids, suggesting that they also participate in 
substrate binding and/or catalysis.  
 
B.1.2.1.2. Farnesyl cysteine-carboxyl methyltransferase from A.thaliana 
 
The plant CAAX processing machinery is evolutionarily conserved. The 
Arabidopsis CAAX proteases AtSte24 and AtRce1 can complement 
corresponding yeast mutants promoting a-factor processing. Proteolysis of plant 
prenylated proteins by AtRce I was sufficient to promote their plasma membrane 
localization in yeast cells. All CAAX processing enzymes are localized in the ER, 
like their homologs in yeast and mammalian cells (Bracha-Drori et al., 2008). 
Plant protein extracts have been shown to contain Icmt activity, and two genes 
encoding Icmt have been cloned. The two genes were designated 
AtIcmtA/AtSte14A and AtIcmtB/AtSte14B (Narasimha Chary et al., 2002). It 
was shown that AtIcmtA and AtIcmtB are differentially expressed and that in 
vitro AtIcmtB had higher catalytic activity. Based on a topology model, Ste14 
contains six membrane spans, with two forming a helical hairpin. AtIcmtB and 
AtIcmtA have similar topology and contain between six to eight transmembrane 
helices.  
 
B.1.3. Stearoyl-CoA 9-desaturase 
 
Fatty acid desaturases introduce a double bond in a specific position of long-chain 
fatty acids. Unsaturation of a fatty acid chain is a major determinant of the 
melting temperature of triglycerides as well as of the fluidity of biological 
membranes that are made up of a bilayer of phospholipids. Thus, fatty acid 
desaturases are conserved across kingdoms. In addition to this fundamental 
function of maintaining the physical property of phospholipids and triglycerides, 
another class of unsaturated fatty acids such as arachidonic acid (20:4 n-6) and 
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docosahexaenoic acid (22:6 n-3) is essential for many physiological functions in 
animals including humans.  
 
B.1.3.1.Classification and characteristic features of desaturases 
 
Fatty acid desaturases are nonheme iron-containing enzymes. Delta desaturases 
create a double bond at a fixed position counted from the carboxyl end of fatty 
acids, whereas omega desaturases act on a specific position counted from the 
methyl end of a fatty acid. This reaction requires molecular oxygen, NAD(P)H, an 
electron transport system (ferredoxin-NADPH reductase and ferredoxin, or 
cytochrome b5 reductase and cytochrome b5), and a terminal desaturase. 
Desaturases can be classified into two groups: soluble desaturases and membrane-
bound desaturases. Acyl-acyl carrier protein (ACP) desaturases are soluble 
desaturases, which are exclusively localized in the plant plastid. These enzymes 
require NADPH and oxygen, and are associated with an electron transport 
sequence comprising ferredoxin-NADPH reductase and ferredoxin. Acyl-ACP 
desaturases contain two atoms of iron and the two D/EXXH motifs of amino acid 
sequence involved in binding the di-iron complex (Shanklin and Cahoon, 1998; 
Sperling et al., 2003). 
Membrane-bound desaturases can be divided into two subgroups. One is the acyl-
lipid desaturases. This group of enzymes is localized in the membranes of 
cyanobacterial thylakoid, plant endoplasmic reticulum, and plastid. Acyl-lipid 
desaturases use either ferredoxin (in cyanobacteria and plant plastid) or 
cytochrome b5 (in plant ER) as an electron donor. Ferredoxin, a soluble protein, 
acts as an electron donor for both acyl-ACP desaturases and acyl-lipid desaturases 
in plant plastid. Acyl-lipid desaturases in cyanobacteria and plant plastid can 
desaturate stearic (18:0) and oleic (18:1 n-9) acyl groups in monogalactosyl 
diacylglycerol (cyanobacteria and plant plastid) and in phosphatidylglycerol (plant 
plastid), whereas plant ER desaturases mostly use fatty acid in 
phosphatidylcholine (Tocher et al., 1998). 
The other subgroup of membrane-bound desaturases is the acyl-coenzyme A 
(CoA) desaturases. These desaturases are present in ER membrane and use fatty 
acyl-CoAs as substrates. Like ER-bound acyl-lipid desaturases, acyl-CoA 
desaturases require cytochrome b5 as an electron donor. Acyl-CoA desaturases 
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are present in animals including insects and nematodes as well as in fungi. All 
mammalian desaturases identified are acyl-CoA desaturases. Analysis of the 
predicted amino acid sequences of membrane-bound desaturases indicates that 
these enzymes contain two long hydrophobic domains that would be capable of 
spanning the membrane bilayer twice. Sequence comparison has also revealed the 
existence of three regions of conserved His-box motifs that contain eight histidine 
residues: HX3-4H, HX2-3HH, and H/QX2-3HH. These histidine residues are 
potential ligands of iron atoms and act at the catalytic center of desaturases 
(Nakamura and Nara, 2004).  
There are many similarities between the chemistry performed by soluble and 
membrane-bound desaturases but there are also notable differences (Shankin et 
al., 2009). The crystal structure of acyl-ACP desaturase shows that these 
desaturases are homodimeric proteins, with each monomer folded into a compact 
single domain composed  of nine helices. The diiron active site of these enzymes 
is buried within a core four-helix bundle and is positioned alongside a deep, bent, 
narrow hydrophobic cavity in which the substrate is bound during catalysis. It is a 
textbook example of a lock-and-key type of binding site in which the bound fatty 
acid moiety is poised for formation of the cis-fatty acid product (Moche et al., 
2003; Whittle et al., 2005; Guy et al., 2007). 
The membrane desaturase active site, on the other hand, seems to have a 
fundamentally different architecture from that of the soluble desaturases, perhaps 
having a cleft into which substrates enter laterally rather than a deep binding 
cavity into which substrates enter in extended conformation as in the soluble 
desaturases. The two classes of desaturases exhibit also different rate-limiting 
steps. For the membrane desaturases, the initial C–H bond-breaking step is rate-
limiting. The limiting step for the soluble desaturase may be the release of acyl-
ACP product, which involves the energetically unfavorable solvation of the 
hydrophobic product as it leaves the hydrophobic cavity and enters the aqueous 
phase. This is in contrast to what is observed in membrane desaturases, in which 
the lipid-linked product is released into the lipids of  the membrane. 
Three desaturases are known in humans. Stearoyl CoA desaturases (SCDs, also 
called ∆9 desaturases) catalyze the synthesis of monounsaturated fatty acids, 
whereas ∆6 desaturase (D6D) and ∆5 desaturase (D5D) are required for the 
synthesis of highly unsaturated fatty acids. 
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B.1.3.1.1.Mammalian stearoyl-CoA desaturase 
 
In mammals, the SCD reaction is an aerobic process requiring molecular oxygen, 
NAD(P)-cytochrome b5 reductase, and the electron acceptor cytochrome b5. The 
electrons flow from NAD(P)H via cytochrome b5 reductase, to cytochrome b5, to 
SCD, and finally to O2, which is reduced to H2O. The enzyme complex introduces 
a single double bond at the ∆9,10 position of long-chain acyl-CoAs (Fig.1.12) 
either from de novo synthesis or from the diet. Based on kinetic isotope data of 
plant desaturase, the current hypothesis for the desaturation reaction is that the 
enzyme removes hydrogen atoms starting with that at the C-9 position, followed 
by the removal of the second hydrogen atom from the C-10 position.  
 
 
 
Fig.1.12. The pathway of electron transfer in the desaturation of fatty acids by stearoyl-CoA 
desaturase (Paton and Ntambi, 2008). 
 
This stepwise mechanism is highly specific for the position at which the double 
bond is introduced, implying that the C-9 and C-10 bond is accurately positioned 
with respect to the diiron center of the enzyme (Paton and Ntambi, 2008). 
The genes for SCD have been cloned from different species, including yeast, 
D.melanogaster, C.elegans, sheep, hamster, rat, mice, and human. In the mouse, 
four isoforms (SCD-1, SCD-2, SCD-3, and SCD-4) have been identified, whereas 
in the rat, two isoforms have been characterized. Humans express two ∆-9 
desaturase genes designated SCD-1 and SCD-5, with the former exhibiting nearly 
ubiquitous expression and the latter being restricted primarily to the brain and 
pancreas. 
SCD-1 contains four transmembrane domains with both the NH2 and COOH 
termini oriented toward the cytosol. The single cytoplasmic loop and the COOH 
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terminus contain the eight histidine residues known to form the His box, which 
binds iron within the catalytic center of the desaturase (Fig.1.13). The two ER 
luminal loops are relatively small compared with the cytosolic loop, which houses 
two of the three conserved His motifs. Purified SCD-1 migrates as a 37-kDa band 
on SDS-PAGE with the His segments located at positions 119, 156, and 296. 
These regions are expected to be necessary to provide ligands for nonheme iron 
within the catalytic site of the enzyme.  
Studies with tissue cultures (Gomez et al., 2002), of mouse, and rat livers 
(Heinemann et al., 2003) have shown that mammalian SCD activity is tightly 
regulated at the transcriptional, translational, and post-translational levels. 
Transcription is under control of the PPARγ signaling pathway (Miller and 
Ntambi, 1996), and may also respond to various secondary messengers such as 
polyunsaturated fatty acids. Translational regulation is mediated through mRNA 
stability by endoplasmic reticulum membrane proteins, like Mga2p (Martin et al., 
2007), and, as recently suggested, the 15-lipoxygenase-differentiation control 
element, a conserved feature in mammalian 3′-untranslated regions (Ren et al., 
2004). Other studies in murine microsomes (Heinemann et al., 2003) and 
differentiated mouse 3L3-L1 adipocytes (Kato et al., 2006) showed post-
translational proteolytic processing of the N-terminus of the enzyme, subsequent 
inactivation, and proteosome-directed degradation.  
 
 
 
Fig.1.13. Proposed model for the membrane topology of mouse SCD-1. The highlighted 
residues represented the conserved histidine regions, which are catalytically essential(Paton 
and Ntambi, 2008). 
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Recent studies on SCD1 suggest that the enzyme is a critical control point of lipid 
homeostasis and body-weight regulation. As several manifestations of the 
metabolic syndrome and type 2 diabetes mellitus – including insulin resistance, 
hypertension, dysfunction of pancreatic b-cells and liver steatosis – are associated 
with intracellular lipid accumulation, it was proposed that SCD may be a potential 
therapeutic target in the treatment of obesity and the metabolic syndrome. 
Increased SCD activity was found in humans and animals with hepatic steatosis, 
whereas SCD1 deficiency ameliorates both high-fat diet and genetically induced 
liver steatosis. SCD1-/- mice are resistant to diet-induced obesity, have increased 
energy expenditure, reduced adiposity and increased insulin sensitivity. In 
addition, SCD1 is involved in adipocyte differentiation and could be important in 
the synthesis of N- oleoylethanolamide, which is known to inhibit food intake and 
stimulate lipolysis. Taken together, the findings reveal SCD to be a promising 
therapeutic target for the treatment of obesity, diabetes, liver steatosis and other 
metabolic diseases. However, the potential use of an SCD inhibitor as a human 
therapeutic agent awaits a more complete understanding of the mechanism 
underlying the effects of SCD deficiency and indication that the inhibition of this 
enzyme is both safe and efficacious (Dobrzyn and Ntambi, 2005; Flowers and 
Ntambi, 2009). 
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C. Aim of the project 
 
The aim of this thesis work is the heterologous expression, purification and 
crystallization of three enzymes in order to determine their three-dimensional 
structure by means of X-ray protein crystallography. 
 
Firstly, the human bile acid coenzyme A:amino acid N-acytransferase (BAAT) 
was chosen for a large-scale production. BAAT is a key enzyme in bile acid 
biosynthesis and catalizes the conjugation of bile acids to glycine and taurine for 
excretion into bile. Bile acid amidation is important for the absorption of fat 
soluble substances, such as fat soluble vitamins, in humans. Mutations in the 
enzyme due to genetic defects are correlated to several pathologies linked to the 
lack of these essential substances. BAAT is believed to contain an α/β hydrolase 
catalytic domain in the C-terminal region, with a Cys-His-Asp catalytic triad. 
However, until now no structural information is available for this enzyme. 
Analysis of its biochemical and structural features may help to understand the 
catalytic mechanism and its proposed but not yet confirmed role in the protection 
against the accumulation of free bile acids.. 
Secondly, a new GFP-based scheme for the overexpression and purification of 
eukaryotic membrane proteins in Saccharomyces cerevisiae was adopted to 
quickly identify those targets that could be selected as good targets for 
crystallization studies (Newstead et al., 2007; Drew et al., 2008). Using this 
protocol, many genes can be rapidly cloned by homologous recombination into a 
GFP-fusion vector and their overexpression potential determined using whole-cell 
and in-gel fluorescence. The quality of the overproduced eukaryotic membrane 
protein-GFP fusions can then be evaluated using confocal microscopy and 
fluorescence size-exclusion chromatography (FSEC). The purification of targets 
that pass the quality criteria can be scaled up to obtain the sufficient amount of 
pure membrane protein for structural studies. 
The most promising targets were selected among 96 C.glabrata membrane 
proteins. This part of the work was carried out in the MPC group, Imperial 
College, London under the supervision of the Prof. B. Byrne. The project started 
from a collaboration with  Prof. K.Haynes, Imperial College, London. The Haynes 
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group is interested in understanding the molecular basis of fungal virulence and 
their research focuses on the pathogen C.glabrata, the major fungal pathogen in 
humans. The application of the new GFP- based method was useful to sort out 
interesting C.glabrata protein targets for functional and structural studies. 
Thirdly, it was decided to study the human membrane enzyme stearoyl-CoA 
desaturase (SCD), a key and highly regulated enzyme that is required for the 
biosynthesis of monounsaturated fatty acids. SCD catalyzes the ∆9-cis 
desaturation of a range of fatty acyl-CoA substrates; the preferred substrates are 
palmitoyl- and stearoyl-CoA, which are converted into palmitoleoyl- and oleoyl-
CoA respectively. SCD appears to be an important metabolic control point, and 
inhibition of its expression could be of benefit for the treatment of obesity, 
diabetes, and other metabolic diseases.  
The multiple layers of regulation of desaturase activity, in diverse organisms, 
emphasize the importance of this enzyme in cellular function, but also complicate 
recombinant expression using living hosts. Until now there are no reports on a 
successful purification and no structural information about this class of proteins. 
The structure determination of a member of the membrane desaturases would 
drastically improve our understanding of the structure-function relationships of 
this protein family. In this thesis work, preliminary attempts to identify a protocol 
for the expression and purification of functional desaturases from different 
organisms were carried out.  
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2.1.Cell strains  
 
2.1.1. Escherichia coli strains 
 
XL1-Blue were used for routine cloning applications.  
 
Genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB 
lacIqZ∆M15 Tn10 (Tetr)] 
 
BL21 (DE3) cells were used for protein expression.  
 
They are an all purpose strain for high-level protein expression and easy induction. 
Genotype: E. coli B F– dcm ompT hsdS(rB– mB–) gal λ(DE3) 
 
BL21 (DE3) C41 cells were used for protein expression.  
 
They are effective in overexpressing toxic proteins from all classes of organisms, 
eubacteria, archaea, yeast, plant, mammals. The strain C41(DE3) was derived 
from BL21(DE3) [E. coli B F– dcm ompT hsdS(rB– mB–) gal λ(DE3)]. This strain 
has at least one uncharacterized mutation, which prevents cell death associated 
with the expression of toxic recombinant proteins. 
 
BL21 CodonPlus(DE3)-RIPL cells were used for membrane protein expression.  
 
BL21-CodonPlus strains are engineered to contain extra copies of genes that 
encode the tRNAs that most frequently limit translation of heterologous proteins 
in E. coli. Availability of tRNAs allows high-level expression of many 
heterologous recombinant genes in BL21-CodonPlus cells that are poorly 
expressed in conventional BL21 strains. 
Genotype: E. coli B F– ompT hsdS(rB– mB–) dcm+ Tetr gal λ(DE3) endA Hte 
[argU proLCamr] [argU ileY leuW Strep/Specr] 
 
Like the parental BL21(DE3) strain, C41(DE3) and CodonPlus(DE3) carry the 
lambda DE3 lysogen which expresses T7 RNA polymerase from the lacUV5 
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promoter by IPTG induction. As E. coli B strains, these are general protein 
expression strains that lack both the lon protease and the ompT outer membrane 
protease, which can degrade proteins during the purification steps. 
 
2.1.2. Saccharomyces cerevisiae strains 
 
FGY217 were used for membrane protein expression.  
 
In this cell line the vacuolar endopeptidase Pep4p is deleted. Deletion of the pep4 
gene not only inhibits Pep4p protease activity but also reduces the levels of other 
vacuolar hydrolases.  
Genotype: MATa, ura3-52, lys2∆201, pep4∆ 
 
2.1.3. Insect cell lines 
 
SF9 (Invitrogen™).  
 
This line originated from the IPLBSF-21 cell line, derived from the pupal ovarian 
tissue of the fall army worm, Spodoptera frugiperda. Sf9 cells grow both in 
monolayer and suspension culture and they are adaptable to a serum-free medium. 
The Sf9 cell line is a clonal isolate of IPLBSF21-AE (Sf21). They are suitable for 
transfection, plaque purification, generating high titer stocks, plaque formation 
and expression of recombinant proteins.  
 
High Five ™ (Invitrogen™).  
 
This line is originated from the ovarian cells of the cabbage looper, Trichoplusia 
ni. They double in less than 24 hours and grow well in adherent cultures, but form 
irregular monolayers. They are adaptable to suspension culture and serum-free 
medium and provide 5-10 fold higher secreted expression than Sf9 cells. High 
Five cells are excellent for expressing recombinant proteins.  
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2.2. Vectors 
 
2.2.1. Cloning in pET15 vector 
 
 
 
Fig.2.1. Schematic representation of pET15 plasmid. 
 
The gene of interest is cloned in pET15 vector for heterologous expression in 
E.coli. This vector adds a 6Histag to the N-terminus of the protein and holds a T7 
promoter and ampicillin resistance (see Fig.2.1).  
 
2.2.2. Cloning in pDDGFP-2 vector 
 
 
 
Fig.2.2. Schematic representation of p424GAL1 plasmid. 
 
The genes of interest are cloned by homologue recombination in pDDGFP-2 
vector for the heterologous expression in Saccharomyces cerevisiae. This plasmid 
harbors a GAL1 promoter and URA selection marker; pDDGFP-2 vector derived 
from p424GAL1 vector (see Fig 2.2). It was modified by D. Drew (Newstead et 
al., 2007) by cloning the sequence for yEGFP with a C-terminal octa-His tag and 
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a TEV protease site. In addition, a SmaI site was inserted before the TEVp-GFP-
8His sequence. Sequences of interest are amplified with primers that include 5’ 
overhangs complementing the upstream and downstream sequences to either side 
of the SmaI site in the GFP-8His vector. Digestion of vector with SmaI gives rise 
to blunt ends that eliminate background colonies caused by re-annealing of the 
linearized vector during transformation by homologue recombination (see 
Fig.2.3). 
 
 
 
Fig.2.3. Cloning by homologous recombination into S.cerevisiae GFP-fusion vector. (a) The 
amount of PCR and vector used in cloning is depicted in the UV-exposed agarose-gel inset: i, 
SmaI linearilized vector; ii, amplified gene with overhangs required for homologous 
recombination. (b) Cloning site used GFP-fusion vector pDDGFP-2. TEV, tobacco etch 
virus; yEGFP, yeast-enhanced green fluorescent protein (Drew et al.,2008). 
 
2.2.3. Cloning in pENTR-D-TOPO and BaculoDirect™Baculovirus 
Expression Systems  
 
Cloning cDNA in this plamid (see Fig.2.4) allows to generate an entry clone with 
attL sites; in this case the gene of interest is then transferred into the 
BaculoDirect™ Linear DNA by using LR reaction for the heterologous 
expression in insect cells. The LR reaction facilitates recombination of an attL site 
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substrate (entry clone) with an attR substrate (BaculoDirect™ C-Term Linear 
DNA) to create an attB-containing expression virus.  
 
 
 
Fig.2.4. Schematic representation of pENTR™/D-TOPO® plasmid. 
 
2.3. Experimental techniques 
 
2.3.1. Plasmid DNA preparation 
 
All plasmid purifications were prepared by using the GenElute™ Plasmid 
Miniprep Kit (Sigma).  
 
2.3.2. Agarose gel electrophoresis  
 
DNA samples were diluted in agarose gel loading buffer and resolved on agarose 
gel (0.8 % agarose, SYBR® SAFE DNA gel stain dissolved in TBE). 
Electrophoresis was performed at room temperature (100 volts, 1 hours) in the 
agarose gel running buffer. 
 
2.3.3. Transformation of competent cells  
 
Transformations of the gene-vector construct into chemically competent for cells 
of all bacterial strains were performed following a standard protocol.  
For chemical transformation, cells are grown to mid-log phase, harvested and 
treated with divalent cations (in this case CaCl2). Cells treated in such a way are 
said to be competent. To chemically transform competent cells, they are mixed 
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with the DNA, in ice, followed by a brief heat shock. Then, the cells are incubated 
with LB medium and allowed to express the antibiotic resistant gene for 30-60 
minutes before plating. 
Transformation of S.cerevisiae is similar to that applied to E.coli. Intact yeast 
cells, which have been harvested during the logarithmic phase of growth, are 
treated with a lithium acetate solution, followed by a polyalcohol treatment (in 
this case PEG 3350), that facilitates the DNA uptake. Addition of carrier DNA 
(single-stranded carrier DNA, salmon sperm) also promotes the uptake of vector 
DNA (Drew et al.,2008).  
 
2.3.4. Insect cell transfection (BaculoDirect™Baculovirus Expression System, 
Invitrogen) 
 
Cellfectin
® 
Reagent is provided with the BaculoDirect™ Expression and 
Transfection Kits for lipid-mediated transfection of insect cells (Sf9 cell line) with 
LB recombination reaction. Cellfectin
® 
Reagent is a 1:1.5 (M/M) liposome 
formulation of the cationic lipid N, NI, NII, NIII-Tetramethyl-N, NI, NII, NIII-
tetrapalmitylspermine (TM-TPS) and dioleoyl phosphatidylethanolamine (DOPE) 
in membrane-filtered water. Budded virus should be released into the medium 96 
hours after transfection. Once the cells appear infected, the virus has to be 
harvested from the cell culture medium (V0 viral stock). The V0 viral stock is a 
low-titer stock (1x105-1x106 pfu/ml). Cells were infected with the V0 stock to 
generate a high-titer V1 stock of approximately 5x107-1x108 pfu/ml. This V1 viral 
stock can then be used to generate a large-scale, high-titer viral stock (V2 viral 
stock) suitable for expression studies.  
 
2.3.5. Recombinant protein induction 
 
All bacterial large volume cultures were performed in a 5 l Erlenmeyer flask in 
liquid LB medium supplemented with the appropriate antibiotics. An overnight 
culture was diluted to an OD600 of 0.15. Cells were grown at 37°C in an orbital 
shaker to an OD600 of 1.0. Protein expression was induced by adding 0.5 mM 
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IPTG and leaving the culture overnight, depending on the protein, at the optimal 
temperature for expression. 
All yeast large volume cultures were performed in Tunair 2.5 l full baffled shaker 
flask (VWR) in liquid URA medium (with 0.1% glucose) diluting an overnight 
culture (liquid URA medium with 2% glucose) to an OD600 of 0.12. Cells were 
grown in an orbital shaker at 30°C; at an OD600 of 0.6 (after ~7 hours) expression 
of the GFP-fused protein was induced with 2% galactose for 22 hours. 
To identify the best expression conditions for each recombinant protein, several 
small volume culture expression trials were performed in 50 ml tubes. After 
induction cells were harvested by centrifugation at 8.000g for 10 minutes at 4°C 
and the cell pellet was stored at -80°C.  
 
All large suspension insect cell cultures were prepared in Erlenmeyer flasks after 
growing enough log phase adherent cells to start a culture of the desired size with 
1x106 cells/ml. Cells were infected using an appropriate volume of V2 viral stock. 
Maximum expression of proteins (non secreted) is generally observed between 
48-96 hours post-infection.  
For recombinant protein expression in insect cells small expression adherent 
cultures were prepared testing different volumes of V2 viral stock and different 
infection times. After infection cells were harvested by centrifugation at 5.000g 
for 5 minutes at 4°C and cell pellets were stored at -80°C. For the Sf9 cell line, the 
cell pellet was washed with PBS buffer to remove any serum protein 
contamination. 
 
2.3.6. Screening of membrane protein overexpression using whole-cell and in 
gel-fluorescence 
 
Cloning in pDDGFP-2 vector (see 2.4.2) allows to follow the protein expression 
measuring the GFP fluorescence. After induction, 200 µl of cell suspension can be 
transferred to a black Nunc 96-well optical bottom plate; GFP fluorescence 
emission was measured at 512 nm by excitation at 488 nm. The membrane protein 
overexpression level (in mg/l) was estimated as describe in Drew et al. (2008) was 
used. The cell suspension was then transferred in a 1.5 ml capped tube and 
disrupted by vortexing or using a mixer-mill disruptor set at 30 Hz with glass 
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beads. Unbroken cells were removed by centrifugation at 22000g for 5 seconds at 
4°C. To pellet crude membranes, the supernatant was centrifuged at 22000g at 
4°C for 1 hour. Crude membranes were resuspended and loaded on a SDS-PAGE 
gel to check for fluorescent bands (see 2.5.8.2). 
 
2.3.7. SDS-PAGE for protein analysis 
 
2.3.7.1. Standard SDS-PAGE 
 
Protein samples were diluted in SDS-PAGE loading buffer, denatured at 95ºC for 
5 min and resolved on denaturing polyacryamide gels. Electrophoresis was 
performed at room temperature (200 volts, 1 hours) in SDS-PAGE running buffer. 
 
2.3.7.2. In gel-fluorescence 
 
To visualize membrane proteins fused to GFP on a SDS-PAGE, a Novex 12% 
Tris-Gly gel (Invitrogen) was used. Protein samples were diluted with in gel-
fluorescence loading buffer. After running ( see 2.5.8.1), the gel was rinsed with 
H2O and the fluorescent bands were detected with a CCD camera system. The gel 
was exposed to blue light (EPI source) set at 460 nm with a cut-off filter at 515 
nm.  
 
2.3.8. Western blotting 
After SDS-PAGE proteins are transferred to a PVDF membrane (100V for 1hour 
on ice) where they are probed using Monoclonal Anti-polyHistidine-Peroxidase 
antibody produced in mouse (Sigma). 
 
2.3.9. Recombinant proteins extraction 
  
Bacterial cell pellets were resuspended in 25 ml of CRB(1) or CRB(2) per liter of 
original cell culture and sonicated on ice. Lysate were subsequently centrifuged at 
8000g for 10 minutes at 4°C. Yeast cell pellets were resuspended in 25 ml of 
CRB(2) per liter of original cell culture and broken using a heavy-duty cell 
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disruptor with four passes at incremental pressures of 25, 30, 32 and 35 kpsi (1.7-
2.4 x103 atm) at 4-15 °C. The lysate was subsequently centrifuged at 8000g for 10 
minutes at 4°C. To remove the unbroken cells and debris the lysate was 
centrifuged at 10000g at 4 °C for 10 minutes. Insect cell pellets were resuspended 
in 1/10 of the original cell culture volume. Cell were disrupted using CBR(2) 
buffer with 1% detergent and leaving 1 hour at 4°C  with mild agitation.  
To purify soluble proteins the cleared supernatant was directly loaded onto an 
affinity column. For membrane proteins, cell membranes were collected from the 
cleared supernatant by centrifugation at 100000g at 4°C for 120 minutes. 
 
2.3.9.1. Membrane protein solubilization 
 
In this study detergent screening was carried out using N,N-
Dimethyldodecylamine N-oxide (LDAO; Anatrace, cat. no. D360), n-Decyl-b-D-
maltopyranoside (DM; Anatrace, cat. no. D322), n-Dodecyl-b-D-maltopyranoside 
(DDM; Anatrace, cat. no. D310), Fos-choline 12 (Anatrace, cat. no. F308) and 
Polyethylene(9)dodecyl ether (C12E9; Anatrace, cat. no. AP0129) (see Tab.2.1). 
 
Detergent Molecular weight Aggregation number CMC (%) 
LDAO 229.41 76 0.023 
DM 482.6 69 0.87 
DDM 510.6 78-149 0.0087 
Fos-choline 12 351.5 54 0.047 
C12E9 avg. 583 - 0.003 
 
Tab.2.1. Physical properties of commonly used detergents. 
 
For membrane proteins the use of a cleavable green fluorescent protein (GFP) 
with a histag fused to the C-terminus of the protein has proved to be very effective 
as a way of following the protein during purification, a technique pioneered by 
Prof. Jan-Willem De Gier and Eric Gouaux. To be successful with this expression 
system, the target membrane protein must have a cytoplasmic C-terminus, since 
the GFP can only be correctly folded and become fluorescent in the cytoplasm. 
GFP fusion proteins expressed S. cerevisiae allow rapid selection of targets with 
the highest expression yields for large-scale purification. In-gel fluorescence 
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analysis and fluorescence size-exclusion chromatography (FSEC), GFP fusion 
proteins clearly show whether a protein is monodisperse in particular detergents 
without the need of any purification step. 
 
2.3.10. Confocal microscopy (Leica TCS SP2 upright confocal microscope, 
Leica) 
 
Harvested cells from a 10-ml culture overexpressing the membrane protein fused 
to GFP were resuspended in 1 ml of URA media containing 50% glycerol.  
One microliter of the cell suspension was add to a microscope slide and a 
coverslip was placed on top. The sample was focused on using Köhler 
illumination with an X10 magnification lens and the focal plane was set to zero. A 
drop of lens oil was added changing to the higher magnification oil-immersion 
lens. The brightfield lamp was turned off. The blue light was then turned on, and 
the gross localization of the membrane protein-GFP fusion was estimated. The 
blue light was turned off and using the argon laser and exciting at 488 nm, a 
detailed localization image of the GFP-fusion was captured (emission detection at 
505–535 nm). 
 
2.3.11. Immobilized metal ion affinity chromatography (IMAC) 
 
For both soluble and membrane proteins the first purification step was carried out 
using an appropriate quantity of Ni Sepharose 6 Fast Flow (GE Healthcare) 
packed into a plastic column. Cell lysates or solubilized membranes were slowly 
loaded onto the column. The resin was then washed with CRB(1) or EB with 
increasing concentration of imidazole. The protein of interest was eluted from the 
column with the same buffer containing 250 mM imidazole. 
 
2.3.12. Size exclusion chromatography (SEC) 
 
SEC was carried out using Superdex 200 10/300 GL Tricorn gel filtration column 
(GE Healthcare). The column was equilibrated in TSB or DB and operated at a 
flow rate of 0.5 ml/min connected to an ÅKTA FPLC system (GE Healthcare) . 
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2.3.13. Fluorescence size exclusion chromatography (FSEC) 
 
Detergent-solubilized yeast membranes were subjected to fluorescence size 
exclusion chromatography (FSEC) to measure the ‘monodispersity’ of the sample. 
FSEC was performed injecting the detergent-solubilized sample onto a Superose 6 
10/300  column (GE Healthcare) equilibrated with DB (0.03% DDM) at a flow 
rate of 0.4 ml/min. After a 6 ml flow, the 0.2 ml fractions were collected row-by-
row into a 96-well plate. The plate was read by a plate reader (SpectraMax M2e 
microplate reader). To improve the signal-to-noise ratio GFP fluorescence 
emission was measured at 512 nm with excitation at 470 nm (this wavelength is 
used instead of 488 nm, as it produces a lower background fluorescent signal). 
GFP fluorescence in each well was plotted against the fraction number. 
 
2.3.14. Hydrophobic interaction chromatography 
 
Hydrophobic interaction chromatography was performed using a column packed 
with the hydrophobic resin Lipidex 1000 (PerkinElmer). 
 
2.3.15. Mass spectrometry 
 
Mass spectrometry was performed on an ion trap Esquire 6000 mass spectrometer 
(Bruker-Daltonik, Germany). For protein mass determination (see 3.1.4), spectra 
were acquired in a positive mode. For protein activity analysis (see 3.1.4.1), mass 
spectra were acquired in a negative ion mode over a mass scan range of m/z 50–
1200 for 5 min at a scan rate of 13000 m/z per second. Capillary voltage was 4 kV 
and a dry gas flow rate of 6.5 L/min was used with a temperature of 230 °C. 
 
2.3.16. NMR spectroscopy 
 
One-dimensional (1D) NMR experiments were run on a Bruker 800 US2 equipped 
with a cryoprobe. The experiment was carried out by collecting 512 scans. The 
spectra width was 13 ppm and the frequency offset was 4.7 ppm. The 
experimental temperature was set to 298 K.  
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2.3.17. Dynamic light scattering (DLS) 
 
Measurements were carried out on a Zetasizer Nano (Malvern Instruments). The 
instrument uses light scattering techniques to measure hydrodynamic size, zeta 
potential and molecular weight of proteins. Typical applications of DLS are the 
measurement of the size and size distribution of particles, emulsions and 
molecules dispersed or dissolved in a solution. In this case it was used to 
determine the presence of aggregates before setting crystallisation screenings. 
 
2.3.18. Protein crystallization 
 
Several techniques exist for setting up crystallisation experiments, which include 
vapour diffusion (hanging and sitting drop), microbatch, microdialysis,…In this 
work all crystal screenings were performed manually or by the Mosquito 
Nanodrop Crystallisation robot using the vapour diffusion method.
 
 
2.3.18.1. Crystallization by the vapour diffusion method 
 
In a vapour diffusion experiment, a small droplet (from 200 nl to several µl) of the 
protein solution is mixed with a precipitant solution (usually in a 1:1 ratio) and 
allowed to equilibrate in a sealed chamber against a reservoir containing a larger 
volume of the precipitant solution. Since the initial concentration of precipitants is 
lower in the droplet than in the reservoir, the droplet dries while gradually 
increasing supersaturation, where nucleation followed by crystal grows occurs. 
 
For crystal sceening performed manually by the hanging drop method, BD 
Falcon™ 24-well Multiwell Plates (Becton Dikinson) were used whereas the 
new Innovadyne/Wilden plates (designed by Jan Lowe of the LMB in Cambridge) 
were adopted for the sitting drop method carried out by the robot.  
 
2.3.18.2. Crystallization screening 
 
In this study the following crystallization screens were used (see Tab.2.2). 
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Screen Company 
Mem-Start & Mem-Sys  Molecular Dimensions Ltd 
MemGold Molecular Dimensions Ltd 
Structure screen (I + II ) Molecular Dimensions Ltd 
PEGRx1 Hampton Research 
 
Tab.2.2. Crystallization screenings. 
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A.3.1.
 
Bile Acid Coenzyme A:Amino Acid N-Acyltransferase  
 
A.3.1.1. Generation of the human BAAT prokaryotic expression vector 
 
For the expression of enzymatically active hBAAT in E.coli, the hBAAT cDNA 
was subcloned into the NdeI-BamHI sites of the bacterial expression vector 
pET15 (see paragraph 2.2.1). The PCR was performed using as template the 
plasmid pOTB7 containing the complete cDNA sequence (IMAGE ID 4071788, 
obtained from RZPD, Deutsches Ressourcenzentrum fuer Genomforschung 
GmbH). The gene was amplified by PCR using the following primers (the coding 
sequence is shown in bold): 
 
BAAT-ET-for: 5’- GGTGGTCATATGATCCAGTTGACAGCTACCCCT - 3’ 
BAAT-ET-rev: 5’- GGTGGTGGATCCTTAGAGTTGACTGGTCACATC - 3’ 
 
CATATG: NdeI restriction site 
GGATCC: BamHI restriction site 
 
Template DNA and primers were subjected to the program A (see appendix, 
paragraph 3). PCR reactions were extracted from agarose gel using the 
GenElute™Gel Extraction Kit (Sigma) and digested with NdeI-BamHI. The 
resultant PCR product was cloned into pET15 giving the expression vector 
hBAAT-pET15; XL1Blue cells were transformed using the ligation reaction and 
positive colonies were selected by colony PCR (see appendix, paragraph 3-
program C). The resulting constructs were confirmed by restriction digestion and 
DNA sequencing. 
At the same time the human BAAT sequence was also cloned into the bacterial 
vector pQE50 that harbors a C-terminal His-tag.  
 
A.3.1.2. Bacterial expression of human BAAT 
 
The constructs hBAAT-pET15 and hBAAT-pQE50 were transformed into several 
E.coli strains (for the transformation protocol see paragraph 2.3.3). Numerous 
small-scale expression trials were set up using different induction temperatures. 
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All cell strains transformed with hBAAT-pQE50 did not show the presence of 
soluble protein (data not shown). On the other hand, the presence of soluble 
BAAT protein was detected in the following strains: SG13009 (pREP4), Origami, 
ER2566, BL21 (DE3), Rosetta (DE3) and BL21 C41 (DE3)) transformed with 
hBAAT-pET15. The best overexpression level was demonstrated in BL21 C41 
(DE3) strain.  
 
 
 
 
 
Fig. 3.1. 12% standard SDS-PAGE: expression trials of hBAAT in Bl21 C41 (DE3). Samples 
harvested 1) before induction, 2) after induction overnight at 16°C, 3) after induction 
overnight at 20°C, 4) after induction overnight at 28°C and 5) after induction overnight at 
37°C. T: total cell fraction, S: soluble cell fraction, M: protein ladder. 
 
                                                          
 
 
Fig.3.2. Western blot analysis: overexpression of hBAAT in Bl21 C41 (DE3). Samples were 
harvested after induction overnight at 20°C. T: total cell fraction, S: soluble cell fraction, M: 
protein ladder. 
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As shown in the Fig. 3.1 the most attractive condition was the induction with 0.5 
mM IPTG at 20°C overnight. Protein expression was also confirmed by Western 
blot analysis using anti-histidine tag monoclonal antibodies (see Fig. 3.2). 
 
A.3.1.3. Large-scale expression and purification of human BAAT 
 
The selected condition was used to prepare a large-scale culture. Two liters of 
bacterial culture were prepared to purify the protein of interest. The cells were 
resuspended in a Tris-HCl buffer at pH 7.5 containing 0.5 M NaCl, 40 mM 
imidazole and 10 mM β-mercaptoethanol and sonicated. The soluble fraction was 
loaded onto a column packed with 2 ml of Nichel Sepharose 6 Fast Flow resin  
equilibrated with the same buffer. The column was then washed with 10 column 
volumes of CRB(1) with 40 mM imidazole. A second washing step was 
performed with 10 column volumes of CRB(1) with 80 mM imidazole. The 
protein was then eluted with 2-3 column volumes of CRB(1) with imidazole at the 
final concentration of 300 mM.  
This protocol was established after a preliminary purification using a 5 ml column 
of Chelating Sepharose™ Fast Flow (Amersham Biosciences) connected to an 
ÅKTA FPLC system. Elution was performed with a 0-0.5 M imidazole gradient. 
Fig. 3.3 it is shows the absorbance profile at 280 nm. 
 
 
 
Fig. 3.3. Absorbance profile at 280 nm: purification of hBAAT by IMAC applying a manual 
modified gradient of imidazole. BAAT protein starts to be eluted with about 150 mM 
imidazole. 
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The eluted fractions were dialysed against CRB(1) without imidazole; the his-tag 
was removed by proteolytic cleavage by treating the partially purified protein with 
thrombin (1 U of enzyme per mg of protein at 20°C overnight) after the addition 
of 2.5 mM CaCl2. The complete removal of the tag was assessed by SDS-PAGE 
as shown in Fig.3.4. 
 
                                             
 
 
Fig. 3.4. 12% standard SDS-PAGE: 1) protein sample not subjected to the enzymatic 
cleavage, 2) protein sample harvested after digestion overnight at 20°C with thrombin, M: 
protein ladder. 
 
A reverse IMAC was adopted to remove thrombin and some other contaminants 
still present after the first chromatographic step. The protein sample in CRB(1) 
without imidazole was loaded on a column filled with 2 ml of equilibrated resin 
Nichel Sepharose 6 Fast Flow; the column was then washed using CRB(1) with 
10 mM imidazole, 40 mM imidazole, 80 mM imidazole and finally 300 mM 
imidazole to remove the bound material.  
 
                              
 
 
Fig.3.5. 12% standard SDS-PAGE: samples collected during a manual reverse IMAC. 1) 
Flow through with 0 mM imidazole, elution with 2) 10 mM imidazole, 3) 40 mM imidazole, 
4) 80 mM imidazole  and 5) 300 mM imidazole. M: protein ladder. 
 
hBAAT was eluted mainly with 40 mM imidazole (see Fig. 3.5); the sample was 
concentrated using a centrifugal concentrator (cut off 10 KDa) to 0.5 ml and 
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subsequently injected onto a size exclusion Superdex 200 column pre-equilibrated 
with TBS without any reducing agent.  
The Fig. 3.6 shows the SEC trace; the peak indicates that hBAAT is eluted as a 
monodisperse protein. Fractions were collected and analyzed by SDS-PAGE. The 
pure protein was concentrated to 10 mg/ml using a centrifugal concentrator (cut 
off 10 KDa).  
 
 
 
Fig.3.6. Absorbance profile at 280 nm: additional purification step of hBAAT by G200 
chromatography. 
 
The final yield was 1 mg of pure protein per liter of culture. To overcome the 
problem of such a poor yield, other heterologous expression systems were taken 
into consideration. Attempts to express human BAAT in insect cells and plants 
were  not effective because the protein was present only in the insoluble fraction 
of cell lysate (data not shown).  
 
A.3.1.4. Human BAAT sample control  
 
To check the purity and the quality of the sample, 1 µl of concentrated BAAT  
was loaded on a SDS-PAGE and, at the same time, on a Tris-glycine native gel 
(see Fig. 3.8). The native gel shows the absence of aggregates on the prepared 
sample (Fig.3.8, right). 
In addition, the presence of secondary and tertiary structures was confirmed by a 
NMR 1H mono dimensional spectrum; in Fig. 3.9 the presence of peaks around 0 
ppm can be noticed suggesting that the protein is folded. 
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Fig.3.8. 15% standard SDS-PAGE (left) and native Novex 12% Tris-Gly gel (right): BAAT 
purified sample after concentration to 10 mg/ml. M: protein ladder. 
 
 
 
 
Fig.3.9. hBAAT NMR 1H mono dimensional spectrum. 
 
The exact protein mass was determined by electrospray mass spectrometry (see 
Fig. 3.10); the calculated mass agrees very well with the mass deduced from the 
cDNA sequence (46552 Da, see appendix, paragraph 5.1.3). 
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Fig.3.10. MS spectrum of recombinant BAAT. 
 
A.3.1.4.1. Electrospray mass spectrometry assay of human BAAT activity 
 
In addition to bile acids-CoA derivatives, hBAAT hydrolyzes also fatty acyl-
CoAs and/or fatty acids conjugate to glycine (O’Byrne et al., 2003). Since the 
natural substrate of hBAAT is not commercially available and difficult to 
synthesize it was decided to verify the activity of recombinant hBAAT following 
the protocol proposed by O’Byrne et al., (2003). The reaction in this case was 
performed using stearoyl-CoA (Sigma), a CoA-derivative of stearic acid (a 
saturated fatty acid).  
Incubation mixtures were set up containing stearoyl-CoA (100 µM), hBAAT (10 
µg), and taurine (25 mM) in 50 mM potassium phosphate buffer, pH 8. The 
mixtures were incubated for 48 h at room temperature after which they were 
purified using columns packed with the Lipidex 1000 resin. The Lipidex columns 
were equilibrated with 5 ml volumes of chloroform:methanol (2:1), followed by 
95% methanol in water, and finally by water. The incubation mixtures were then 
loaded onto the column followed by a further washing step with 5 ml of water. 
The column was then eluted using 5 ml of methanol, and the eluate was dried 
under nitrogen. The samples containing the stearoyl-CoA reaction products were 
reconstituted in tetrahydrofurane-water (1:1 v/v) and 4-5 µl were analyzed by 
mass spectrometry ( see paragraph 2.3.15). Recombinant hBAAT was incubated 
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with fatty acyl-CoA in both the absence and presence of 25 mM taurine 
(Fig.3.11). 
 
 
 
Fig.3.11. Negative ion electrospray mass spectrometry analysis of BAAT fatty acid 
conjugating activity. The spectrum in A) corresponds to the incubation containing 2-5 µg of 
BAAT and 40 µM stearoyl-CoA and the spectrum in B) corresponds to the incubation 
containing 2-5 µg of BAAT, 40 µM stearoyl-CoA and 50 mM taurine. 
 
The enzyme shows both the N-acyltransferase activity (N-stearoyl taurine peak) 
and the thioesterase activity (stearic acid peak) due to its high degree of homology 
with the type I acyl-CoA thioesterases. 
 
A.3.1.5. Crystallization of human BAAT 
 
Several crystallization trials were set up at different protein concentrations (8 
mg/ml, 10 mg/ml, 15 mg/ml, 20 mg/ml). The protein sample was prepared in the 
absence or in the presence of ligands. A batch of holo-enzyme was obtained 
adding 5mM cholate/5 mM glycine, 5 mM cholate/5 Mm taurine or 5 mM 
glycocholate. In fact, it was noticed that BAAT binds to a cholate and a 
glycocholate affinity column (Vessey, 1978). Although the recombinant hBAAT 
could be purified at an appreciable level (1 mg/L), up to now no crystals grew 
from the trials prepared. 
 
A.3.1.6.Generation and expression of human BAAT mutants 
 
To abolish thioesterase activity the catalytic mutant BAAT C235A was prepared. 
Furthermore, examination of the protein sequence shows also the presence of a 
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couple of cysteines in positions 372-373 (see appendix paragraph 5.1.3). Since 
cysteines could form non physiological inter- and/or intramolecular disulfide 
bridges and therefore be a source of sample microheterogenity, a second double 
mutant was prepared, C372-373A. A third triple mutant C235A-C372/3A with no 
cys residues was also expressed. The original pET15-BAAT plasmid was used as 
a template and four primers were ordered. The primer sequences were the 
following: 
 
BAAT-C235A-for: 5’- GTAGTCTCTGTAGCTCAAGGAGTACAG - 3’ 
BAAT-C235A-rev: 5’- CTGTACTCCTTGAGCTACAGAGACTAC - 3’ 
 
BAAT-C372/3A-for: 5’- TATTCTCCTCTGGCGGCCGCCTCAACGACC - 3’ 
BAAT-C372/3A-rev: 5’- GGTCGTTGAGGCGGCCGCCAGAGGAGAATA - 3’ 
 
PCR was performed as described in appendix, paragraph 3 (program B); PCR 
products were then digested with the DpnI restriction enzyme to eliminate the 
original template. XL1Blue cells were transformed with the reaction and several 
colonies were sequenced. Positive mutant plasmids were used to transform BL21 
(DE3) C41 cells.  
 
                                                      
 
 
Fig.3.12. Western blot analysis: soluble cell fractions obtained from small-scale expression 
trials of the proteins 1) BAAT wild type, 2) BAAT catalytic mutant form, 3) C372/373A and 
4) C235A-C372/373A. Cells were induced with 0.5 mM IPTG at 20°C overnight. M: protein 
ladder. 
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The mutants were expressed and purified adopting the same conditions used for 
the expression and purification of wild-type hBAAT (see Fig.3.12). 
Fig.3.13 shows SEC traces of wild type BAAT and the three mutants. The purity 
of the four samples was comparable but the yield and the behavior were 
completely different. Yield of the double and the triple mutant was 0.5 mg/l or 
less; in particular the triple mutant did not seem to be monodisperse and it was not 
stable at high concentration.  
 
 
 
Fig.3.13. Absorbance profile at 280 nm: G200 chromatography showing the elution peaks of 
wild type BAAT and the three mutant forms. 
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Sample Z-average (d.nm) Pdl 
BAAT wild type   8.09 0.088 
BAAT C235A 8.75 0.204 
BAAT C372/373A 10.90 0.357 
BAAT C235A C372/373A 23.57 0.825 
 
Fig.3.14. Dynamic light scattering experiments. Measurements were made on a Malvern 
Zeta sizer instrument at 20°C: A) intensity and B) volume size distributions obtained for the 
wild type enzyme and the three mutants, C) z-average diameters and polydispersity index 
(Pdl) of the samples. Red: BAAT wild type, green:BAAT C2372/373A, blue: BAAT C235A-
C372/373A, black: BAAT C235A. 
 
The purification protocol, the storage conditions, the choice of the buffers (pH and 
ionic strenght) and the modification on the amino acid chain (mutagenesis) may 
be crucial to obtain a crystallization quality sample. For this reason, the 
monodispersity of the samples was assessed using the DLS technique. Fig. 3.14 
shows DLS data for the wild type enzyme and the three mutant forms. Samples 
were analyzed in TBS at the concentration of 3 mg/ml and measurements were 
conducted at 20 °C. The samples are clearly different. Visually, the peak shape of 
the double and triple mutant forms suggests the presence of oligomeric assemblies 
and/or aggregates, appreciable even if considering only the size distribution by 
intensity. The associated polydispersity index is greater than 0.2, indicating the 
presence of more than one species. These results preclude their use for 
crystallization trials. Only the catalytic mutant (C235A) appears to be adequate 
for crystallization experiments. 
 
A.3.1.6.1. Crystallization of the catalytic mutant of BAAT C235A 
 
Several crystallization trials were set up at different protein concentrations (10 
mg/ml, 15 mg/ml). The protein sample was prepared in absence or in presence of 
different ligands. A batch of the  holo-enzyme was obtained by adding 5 mM 
stearoyl-CoA. Micro crystals appeared only with the holo-enzyme in 0.1 M Hepes 
pH 7.5, 10% PEG 8000, 8% ethylene glycol as precipitant (Fig. 3.15).  
Several optimization trials were set up to improve the quality of these 
microcrystals but up to now no suitable crystals for X-ray diffraction experiments 
were obtained. 
C 
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Fig.3.15. BAAT C235A microcrystlas obtained with 0.1M Hepes pH 7.5, 10% PEG 8000, 8% 
ethyleneglycol as precipitants.  
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A.3.1. Discussion 
No protocols for the expression and purification of recombinant human BAAT 
had been described in the literature. Here, we describe how the human enzyme 
BAAT was cloned and expressed in E.coli. The purification protocol includes 
three steps: IMAC, reverse IMAC and SEC. Sufficient pure material was obtained 
to set up several crystallization trials. Although the purity and the quality of the 
wild type protein samples were excellent, no crystal was obtained. One of the 
problems might be the presence of large mobile loops that could interfere with the 
formation of molecular contacts inside the crystal. In fact, the use of secondary 
structure prediction programs suggests that large portions on the N-terminal part 
of the protein are unstructured. It was then decided to create a new construct that 
lacks a portion of the amino acid sequence on the N-terminal part but maintains 
the integrity of the catalytic domain with the Cys-His-Asp catalytic triad in the C-
terminal portion. The major problem was to identify stable deletion mutants 
without any information about the secondary structure of the protein. Some 
constructs were cloned but no soluble protein was obtained (data not shown). 
Recently, the crystallographic structure of human mitochondrial acyl-CoA 
thioesterase (ACOT2) was published (Mandel et al., 2009). The enzyme contains 
an α/β hydrolase catalytic domain in the C-terminal region, with a Ser-His-Asp 
catalytic triad. The 3D structure of ACOT2 contains two domains, N and C 
domains.  
 
 
Fig.3.16. Human BAAT 3D model builds using the program HHpred and as a template the 
pdb file of human ACOT2. 
Chapter 3                                                                                                         Results and Discussion 
- 63 - 
The N domain contains a seven-stranded β-sandwich; the active site is located in a 
large pocket at the interface between the two domains.  BAAT shares significant 
amino acid sequence conservation with this type of enzyme. Using the program 
HHpred (Homology detection & structure prediction by HMM-HMM 
comparison) and the ACOT2 3D structure as template, a model of BAAT 3D 
structure was built (see Fig.3.16). This model suggests a hypothetic site where to 
cut the protein sequence. Therefore a new construct was made starting from amino 
acid 135. At the moment preliminary expression and purification studies are in 
progress. Obtaining enough pure material of the catalytic domain could be useful 
to set up crystallization trials but also to conduct activity studies that could help in 
understanding the role of the two domains.  
On the other hand, the generation and purification of the inactive C235A mutant 
allowed the preparation of reproducible crystals that did not grow in any of the 
crystallization trials carried out with the wild type protein. The ongoing 
crystallization experiments are focused on obtaining larger crystals suitable for X-
ray diffraction studies. 
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B.3.1. Two membrane enzymes: Farnesyl Cysteine-Carboxyl 
Methyltransferase and Stearoyl-CoA 9-Desaturase 
 
B.3.1.1. Farnesyl cysteine-carboxyl methyltransferase from C.glabrata 
 
B.3.1.1.1. GFP-based optimization scheme for the overexpression and 
purification of eukaryotic membrane proteins in S.cerevisiae 
 
Obtaining pure membrane proteins in large quantities is fundamental for 
analyzing their biochemical and structural features. In this case a new high-
throughput GFP-based method (Newstead et al., 2007; Drew et al., 2008) was 
used to select some promising targets among 96 C.glabrata membrane proteins. 
 
B.3.1.1.1.1. Controlling membrane protein overexpression using whole-cell 
and in gel-fluorescence 
 
96 cDNAs coding for membrane proteins from C.glabrata were cloned in the 
pDDGFP-2 vector by homologue recombination (see 2.2.3). PCR products and 
linearized vectors were transformed in FGY217 cells as described in paragraph 
2.3.3. For each clone a 10 ml culture was prepared to check the expression level 
and to control the protein integrity (see 2.3.6 and 2.3.7.2). Expression levels of the 
well expressing targets are summarized in Tab.3.1. 
 
Name/Gene Protein Molecular 
weight 
(kDa) 
Position  
in 96 well  
plate 
Fluorescence 
counts 
Expression 
level 
(mg/L) 
 
CAGL0K04367g-F 
 
L-methionine transporter Mup1 
(YGR055w) 
63.1 A5 
25172 
25358 
26610 
1.99 
CAGL0B02079g-F Azole transporter AZR (YGR224w) 68.1 A8 
49095 
43876 
49011 
4.21 
CAGL0M08272g-F Polyamine transporter (YKL174c) 69.7 B1 
32461 
27303 
24767 
2.66 
CAGL0H00847g-F UDP-galactose transporter HUT1 (YPL244c) 40.4 B2 
61314 
60609 
66892 
3.33 
CAGL0F02805 g-F 
Farnesyl cysteine carboxyl-
methyltransferase Ste14 
(YDR410c) 
29 C4 
26885 
30794 
37964 
1.06 
CAGL0H09196 g-F Nucleotide sugar transporter GOG5 (YGL225w) 35.8 C6 
28232 
41188 1.61 
CAGL0K04609 g-F H+/biotin symporter Alg2 (YGR065c) 71.7 C7 
16523 
23655 1.38 
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CAGL0G02453 g-F Peptide transporter PTR2 (YKR093w) 67.8 D1 
22062 
24861 
38666 
1.97 
CAGL0C02123 g-F Telomere maintenance ERY5 (YFR041c) 34.4 E11 
39427 
54928 
18816 
2.16 
CAGL0G04851 g-F Fatty acid elongase activity SUR4 (YLR372w) 41.2 F7 
15873 
15830 0.75 
CAGL0J04378 g-F Oligosaccharide transporter RFT1 (YBL020w) 63.1 H8 
20216 
31455 1.54 
CAGL0M00748 g-F Cell organision and biogenesis ECM7 (YLR443w) 49.6 H10 
23488 
42411 1.45 
 
Tab.3.1. C. glabrata well expressing targets. 
 
Crude membranes extracted from each of the 10 ml cultures were loaded for in-
gel fluorescence detection (see Fig.3.16) to check if a visible band was present. 
 
 
                            
 
Fig.3.16. In-gel fluorescence detection of crude yeast membrane samples isolated after the 
overexpression of 12 different membrane proteins from C.glabrata. M: fluorescent proteins 
ladder. 
 
B.3.1.1.1.2. Optimizing expression with temperature and chemical 
chaperones 
 
In the literature, it has been reported that the addition of chemical chaperones such 
as DMSO (2.5% vol/vol) or histidine (0.04%) to yeast cultures can improve 
membrane protein folding. The effectiveness of these chemical chaperones was 
tested in the expression of these proteins. In Tab.3.2 the expression levels of the 
well expression targets were reported. Because a lower temperature can also 
increase the yield, expression at 20°C for 40 h after GAL1 induction was also 
tested (see Tab.3.3). 
 
155 KDa 
  98 KDa 
  63 KDa 
 
  40 KDa 
 
  31 KDa 
 
  21 KDa 
 
 
  11 KDa 
M    A5  A8   B1   B2          M    C4  C6   C7   D1  E11  F7  H8   H10 
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Clone number Expression level (mg/L) 
without additive with DMSO 2.5% with L-HIS 0.04% 
A5 1.8 1.9 3.1 
B1 2.3 1.5 3.3 
B2 4.4 5.3 4.4 
C7 1.9 1.8 2.2 
F7 0.8 0.7 1.2 
H8 2.5 2.4 2.8 
A8 3.5 2.5 5.3 
C4 1.2 1.3 2 
C6 1.9 2 2.3 
D1 1.5 1.2 1.2 
E11 3.6 4.4 3.6 
H10 2.6 2.9 2.8 
 
Tab.3.2. Expression levels of the 12 well expressing targets after 22 hours of induction at 
30°C with or without additives. 
 
Clone number Expression level (mg/L) 
without additive with DMSO 2.5 % with L-HIS 0.04% 
A5 1.6 1.2 0.4 
B1 1.2 0.5 0.7 
B2 1.7 1.5 0.6 
C7 0.3 0.4 0.2 
F7 0.1 0.1 0.1 
H8 0.8 0.7 0.3 
A8 0.7 2.1 0.8 
C4 1.2 1.2 1.3 
C6 1.4 2.6 1.2 
D1 0.8 0.8 0.4 
E11 3.2 1.8 3.7 
H10 0.9 0.5 0.6 
 
Tab.3.3. Expression levels of the 12 well expressing targets after 40 hours of induction at 
20°C with or without additives. 
 
B.3.1.1.1.3. Assessing the quality of overproduced fusions by FSEC 
 
The best overexpression conditions were chosen for the isolation of the 
membranes from 1 liter of yeast culture. Membrane pellets from 1 liter were 
resuspended in 6 ml of MRB. Membrane suspensions were used for the detergent 
screen (see 2.3.9.1). Initially, solubilization efficiency was tested adjusting 
membrane resuspention to a protein concentration of 3.5 mg/ml in 1 % of the 
detergent of choice, PBS 1X and glycerol 10%. The mixture was incubated at 4°C 
for 1 hour with mild agitation; GFP fluorescence measure was made before and 
after centrifugation at maximum speed for one hour (see Fig.3.17, left). 
FSEC was used to determine whether the detergent extraction efficiency can be 
related to the protein stability (see 2.3.13). Recently, Kawate and Gouaux 
(Kawate and Gouaux, 2006) showed that detergent-solubilized fusion proteins that 
are monodisperse, as judged by FSEC, are typically stable after purification. This 
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correlation removes the need to test each protein-detergent sample separately by 
purification. DDM and LDAO solubilized samples of each fusion construct (500 
µl) were injected onto a size-exclusion column. The criterion for ‘monodispersity’ 
was that the fusion peak was expected to be symmetric and equal to or larger than 
either the aggregate or free-GFP peaks (Alguel et al,.2010).  
 
A5: L-methionine transporter 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A8:  Azole transporter 
 
 
Detergents 
 (1%) 
Fluorescence  
counts 
Percentage 
 (%) 
Membrane  
resuspention 
After  
centrifugation 
DDM  9294 7144 77 
DM 9178 6419 70 
LDAO 9563 8010 83 
Fos-choline 12 9388 9158 97 
C12E9 9508 7182 75 
 
 
 
B1: Polyamine transporter 
 
 
Detergents 
(1%) 
Fluorescence  
counts 
Percentage  
(%) 
Membrane  
resuspention 
After  
centrifugation 
DDM  3143 2271 72 
DM 3016 2196 72.8 
LDAO 3158 2382 75.4 
Fos-choline 12 3021 2486 82 
C12E9 3023 2074 68.6 
 
 
 
B2: UDP-galactose transporter 
 
 
Detergents 
(1%) 
Fluorescence 
counts 
Percentage  
(%) 
Membrane  
resuspension 
After  
centrifugation 
DDM  6958 3522 50 
DM 7148 2593 36.2 
LDAO 6953 3253 46.7 
Fos-choline 12 6248 6200 100 
C12E9 6772 2550 37.6 
 
Detergents 
 (1%) 
Fluorescence  
counts 
Percentage 
 (%) 
Membrane 
resuspention 
After 
centrifugation 
DDM  5503 4624 84 
DM 5810 4281 73.6 
LDAO 6067 4500 74 
Fos-choline 12 5603 5396 96 
C12E9 5684 4055 71 
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C4: Farnesyl cysteine carboxyl-methyltransferase 
 
 
Detergents  
(1%) 
Fluorescence 
counts 
Percentage  
(%) 
Membrane  
resuspention 
After  
centrifugation 
DDM  5330 3897 73 
DM 5478 3495 63.8 
LDAO 5389 4670 86.6 
Fos-choline 12 5326 4884 91.7 
C12E9 5299 3306 62 
 
 
C6: Nucleotide sugar transporter 
 
 
Detergents 
(1%) 
Fluorescence 
counts 
Percentage  
(%) 
 Membrane  
resuspention 
After  
centrifugation 
DDM  10228 7754 75.8 
DM 11276 6349 56.3 
LDAO 11007 7628 69.3 
Fos-choline 12 10746 9891 92 
C12E9 10472 5488 52.4 
 
 
C7: H+/biotin symporter 
 
 
Detergents 
(1%) 
Fluorescence 
counts 
Percentage  
(%) 
Membrane  
resuspention 
After  
centrifugation 
DDM  6738 3484 51 
DM 6876 1845 26 
LDAO 6986 3462 49 
Fos-choline 12 6680 5257 78 
C12E9 7048 4361 61 
 
 
D1: Peptide transporter 
 
 
Detergents 
(1%) 
Fluorescence 
counts 
Percentage  
(%) 
Membrane  
resuspention 
After  
centrifugation 
DDM  8857 5570 62.8 
DM 8624 5435 63 
LDAO 8249 5869 71 
Fos-choline 12 8258 5919 71.6 
C12E 8384 5188 61.8 
 
 
 
E11: Protein involved in telomere maintenance 
 
 
Detergents 
(1%) 
Fluorescence 
counts 
Percentage  
(%) 
Membrane  
resuspention 
After  
centrifugation 
DDM  10940 2462 22 
DM 11359 2619 22.5 
LDAO 15370 4348 28 
Fos-choline 12 10632 8813 82 
C12E9 11038 1927 17 
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F7: Protein with fatty acid elongase activity 
 
 
Detergents 
(1%) 
Fluorescence 
counts 
Percentage  
(%) 
Membrane  
resuspention 
After  
centrifugation 
DDM  2775 1742 62.7 
DM 2609 1471 56 
LDAO 2413 1742 72 
Fos-choline 12 2565 2016 78.5 
C12E9 2433 1695 69.6 
 
 
H8: Oligosaccharide transporter 
 
 
Detergents 
(1%) 
Fluorescence 
counts 
Percentage  
(%) 
Membrane  
resuspention 
After  
centrifugation 
DDM  6712 4319 64 
DM 7212 3566 49.4 
LDAO 6601 4259 64.5 
Fos-choline 12 6326 5827 92 
C12E9 7427 3836 51.6 
 
 
H10: Protein involved in cell organision and biogenesis 
 
 
Detergents 
(1%) 
Fluorescence 
counts 
Percentage  
(%) 
Membrane  
resuspention 
After  
centrifugation 
DDM  8784 2075 23.6 
DM 8395 1790 21 
LDAO 8336 2882 34.5 
Fos-choline 12 7888 6480 82 
C12E9 8902 2304 25.8 
 
 
Fig.3.17. (left) Fluorescence counts before and after centrifugation of solubilized membranes 
obtained from 1 liter of yeast culture overexpressing the selected targets, (right) FSEC 
profile for DDM-(black) and LDAO-(red) solubilized membranes. 
 
Only two or three out of the tested membrane proteins seemed to be promising for 
a successful overproduction. Considering the expression level, the stability after 
solubilization and the medical relevance it was decided to scale up the purification 
of the GFP-fusion C4, Farnesyl cysteine-carboxyl methyltransferase (Ste14), a 
transmembrane enzyme of 29 kDa. Because of its small size, well-characterized 
enzymatic activity, highly hydrophobic nature and pharmaceutical interest, Ste14 
may represent an ideal ‘test case’ for developing methodologies to crystallize 
multispanning integral membrane enzymes, a critically neglected areas of current 
biology. 
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B.3.1.1.1.4. Confirming quality of membrane-integrated expression by 
confocal microscopy  
 
S.cerevisiae has a highly regulated quality control system in the endoplasmic 
reticulum (ER), ER-associated degradation, and only correctly folded proteins exit 
the ER. Misfolded proteins are either retained in the ER until they are folded 
correctly or dislocated from the ER and degraded by the proteasome in the 
cytosol. Proper subcellular targeting of overexpressed membrane proteins 
therefore provides a good indication of correct folding. Global fluorescence-
microscopy localization studies on C-terminally GFP tagged proteins have shown 
that for the majority of proteins, GFP does not interfere with trafficking 
(Newstead et al., 2007).  
Harvested cells from 10-ml culture overexpressing Ste14-GFP, were tested by 
confocal microscopy (see paragraph 2.3.10). Fig.3.18 shows Ste14 GFP-fusion 
localized in membrane organelles, probably endoplasmic reticulum.  
 
        
 
Fig.3.18. Ste14 GFP-fusion localization in S. cerevisiae monitored by confocal microscopy. A) 
Widefield  and B) confocal image of an yeast cell. 
 
B.3.1.1.2. Large-scale expression and purification of the Ste14-GFP fusion 
protein 
 
A 10-liter culture was prepared as described in 2.5.6; induction was conducted 
using the parameters established in the overexpression optimization screen (at 
30°C for 22 hours in the presence of galactose 2% and L-His 0.04%).  
A B 
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Membranes were isolated (see 2.3.9) and resuspended in 60 ml of MRB. The 
membrane resuspension was diluted at a final protein concentration of 3 mg/ml 
using EB. The detergent powder (1%) that produced the most homogeneous 
sample was added. In this case two different purifications were done, the first 
using DDM and the second using LDAO. The purification scheme shown in 
Fig.3.19 was followed. 
 
 
 
Fig.3.19. Flowchart illustrating the purification of Ste 14 from GFP-fusion. (a) Detergent 
solubilization of Ste14-GFP fusion, (b) incubation of supernatant with Ni Sepharose resin, (c) 
IMAC purification, (d) dialysis and cleavage of GFP from Ste14-GFP fusion, (e) reverse 
IMAC to remove GFP and tobacco etch virus (TEV) from Ste14, (f) gel filtration (Drew et 
al., 2008). 
 
The mixture was incubated for one hour at 4°C with mild agitation and then 
centrifuged at 100.000g for 45 minutes to pellet the insoluble material. 1 ml of Ni 
Sepharose 6 Fast Flow per 1 mg of GFP-fusion was added to the supernatant. The 
solution was mixed using a magnetic stirrer at 4°C for 3 hours. Ste14-GFP fusion 
was purified by IMAC: the supernatant was loaded in the presence of 40 mM 
imidazole, the column was washed with EB in the presence of 80 mM imidazole 
and the GFP-fused protein eluted in the presence of 250 mM imidazole. A reverse 
IMAC in the presence of 40 mM imidazole was then performed after cleavage of 
the GFP-His8 tag (during overnight dialysis to remove imidazole) with his-tagged 
tobacco etch virus (TEV) protease. The eluted protein was concentrated using a 
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centrifugal concentrator (cut off 30KDa) and then loaded on a Superdex 200 
10/300 GL Tricorn gel filtration column equilibrated in DB. Each purification step 
could be followed by measuring GFP counts. It was also possible to estimate the 
membrane protein quantity using the methodology detailed in Drew et al. (2008). 
All chromathographic steps were performed in the presence of a reducing agent 
(10 mM β-mercaptoethanol during IMAC and 1 mM DTT during SEC); 
preliminary purifications suggested that the protein dimerized in the absence of  a 
reducing agent (see Fig.3.20). 
 
                                                  
 
 
Fig.3.20. Nu PAGE gel (Invitrogen): Ste 14 protein 2) in the presence and 1) in the absence of 
1 mM DTT. 
 
B.3.1.1.2.1. Purification of Ste14 in DDM  
 
Tab. 3.4. summarizes the information recorded throughout the purification steps 
of Ste14 in DDM (0.03%).  
 
Membrane preparation  
Cells breakage efficiency (%) 67 
Membrane protein in membrane resuspention (mg) 6 
Purification  
Solubility (%) 75 
Binding (%) 80 
Amount of GFP-fusion in elution (mg) 3.6 
 
Tab.3.4. Data-sheet showing information recorded throughout this protocol. 
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Fig.3.21 shows the SEC profile; the membrane protein peak of the UV-trace was 
collected and controlled by SDS-PAGE. 
 
 
 
Fig.3.21. Absorbance profile at 280 nm: G200 chromatography of Ste 14 in DDM 0.03%. 
 
The protein sample was then concentrated to 10 mg/ml using a centrifugal 
concentrator (cut off 30KDa). To check the purity and the quality of the sample, 1 
µl was loaded on a SDS-PAGE (see Fig.3.22). 
 
                                                           
                                                            
 
Fig.3.22. 12% standard SDS-PAGE: Ste14 purified sample after concentration to 10 mg/ml. 
M: protein ladder. 
 
B.3.1.1.2.2. Purification of Ste14 in LDAO 
 
Tab.3.4 reports the information recorded throughout the purification of Ste14 in 
LDAO (0.06%).  
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Membrane preparation  
Cells breakage efficiency (%) 70 
Membrane protein in membrane resuspention (mg) 6 
Purification  
Solubility (%) 95 
Binding (%) 70% 
Amount of GFP-fusion in elution (mg) 4 
 
Tab.3.5. Data-sheet showing information recorded throughout this protocol. 
 
 
 
Fig.3.23. Absorbance profile at 280 nm: G200 chromatography of Ste 14 in LDAO 0.06%. 
 
                                                                      
                 
 
Fig.3.24. 12% standard SDS-PAGE: Ste14 purified sample after concentration to 10 mg/ml. 
M: protein ladder. 
 
Fig.3.23 shows the SEC profile; the UV-trace pack was collected and analysed by 
SDS-PAGE. The protein sample was then concentrated to 10 mg/ml using a 
centrifugal concentrator (cut off 30KDa). To check the purity and the quality of 
the sample, 1 µl was loaded on a SDS-PAGE (see Fig.3.24). 
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B.3.1.1.3. Crystallization trials of Ste14 
 
Several crystal trials were set up at various concentrations of the protein (10 
mg/ml, 15 mg/ml, 20 mg/ml) both with DDM- and LDAO-solubilized Ste14. 
Although the recombinant Ste14 could be purified at an appreciable level, up to 
now no crystals grew from the trials prepared. 
 
B.3.1.2. Farnesyl cysteine-carboxyl methyltransferase from A. thaliana 
 
Since no appreciable result was obtained with these crystallization trials, it was 
decided to express the Ste14 homologue from A.thaliana (AtSte14A) (for a brief 
description see B.1.2.1.2.).  
The AtSte14 amino acid sequence shows 36% identity with the yeast Ste14 and 
45% identity with the human Icmt (see Appendix 2.7). The AtSte14 topology 
model is similar to the topology model of the yeast protein: they have both six 
membrane spans. However, the protein from A.thaliana lacks an N-terminal 
cytoplasmic portion of about 50 amino acids. Due to its small size and the absence 
of disordered portions, this protein could be a better target for crystallization 
experiments. 
 
B.3.1.2.1. Cloning, expression and solubilization attempts 
 
The Ste14A cDNA from A.thaliana was subcloned into the NdeI-BamHI sites of 
the bacterial expression vector pET15 (see paragraph 2.2.1). The PCR was 
performed using as template the plasmid pGEM-T Easy (Promega) containing the 
complete cDNA sequence. The AtSte14 cDNA sequence was amplified from the 
total A.thaliana cDNA (kindly provided by Prof. Furini, University of Verona), 
inserted in pGEM-T Easy and then sequenced to confirm the sequence identity. 
In order to insert the gene in pET15, it was amplified by PCR using the following 
primers (the coding sequence is shown in bold): 
 
STEara-ET-for: 5’- GGTCATATGACAGAGATCTTCAGTGACACC - 3’ 
 
STEara-ET-rev: 5’- GGTGGATCCTTAGTTCACAAATGGAACACCAGA-3’ 
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CATATG: NdeI restriction site 
GGATCC: BamHI restriction site 
 
Template DNA and primers were subjected to program A (see appendix paragraph 
3). PCR reactions were extracted from agarose gels using the GenElute™Gel 
Extraction Kit (Sigma) and digested with NdeI-BamHI. The resultant PCR 
product was cloned into pET15 giving the expression vector Ste14ara-pET15; 
XL1Blue cells were transformed using the ligation reaction and positive colonies 
were selected by colony PCR (see appendix paragraph 3, program C). The 
constructs obtained were confirmed by restriction digestion and DNA sequencing. 
The Ste14ara-pET15 expression vector was transformed into E.coli BL21 
CodonPlus (DE3)-RIPL cells. Several expression trials were carried out at 
different temperatures in order to improve the expression level (see 2.3.5). The 
presence of Ste14 protein was confirmed by Western blot analysis using anti-
histidine tag monoclonal antibodies (see Fig.3.25). 
 
 
 
 
 
Fig.3.25. Western blot analysis: overexpression of AtSte14 in Bl21 CodonPlus(DE3)-RIPL. 
Samples harvested 1) after induction overnight at 16°C, 2) after induction overnight at 20°C, 
3) after induction overnight at 28°C and 4) after induction at 37°C for 3 hours. T: total cell 
fraction, S: soluble cell fraction, M: protein ladder. 
 
The best overexpression condition was chosen (induction at 20°C overnight with 
0.5 mM IPTG) for the isolation of the membranes from 1 liter of culture (see 
2.3.9). Membranes were resuspended in 2 ml of MRB and solubilized in 1% 
DDM and 1% LDAO like described in 3.1.1.2. Ten microliters of the solubilized 
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material before and after ultracentifugation were loaded on an SDS-PAGE and 
Ste14 was visualized by immunodetection using anti-histidine tag monoclonal 
antibodies (see Fig.3.26). Almost the total amount of Ste14 was solubilized in 
LDAO as demonstrated in Fig.3.26; no other detergent is effective in  solubilizing 
this protein (data not shown). 
 
                                                      
 
 
Fig.3.26. Western blot analysis: solubilized material in LDAO 1% harvested 1)before and 2) 
after centrifugation. M:protein ladder. 
 
B.3.1.2.2. Large-scale purification of AtSte14 
 
The selected condition was applied in a large-scale expression experiment. Four 
liters of bacterial culture were prepared to purify the protein of interest.  
 
                                         
 
 
Fig.3.27. 15% standard SDS-PAGE: samples collected during IMAC. 1) Flow through with 0 
mM imidazole, washing with 2) 10 mM imidazole, 3) 40 mM imidazole and 4) 300 mM 
imidazole. M: protein ladder. 
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Membranes were resuspended in 8 ml of MRB and then diluted in EB in the 
presence of 1% LDAO. Detergent-solubilized Ste14 was purified to homogeneity 
using IMAC; the sample was loaded on a column filled with 1 ml of the resin Ni 
Sepharose 6 Fast Flow in the presence of 10 mM imidazole. The column was then 
washed with EB with the addition of 40 mM imidazole and the protein eluted in 
300 mM imidazole (see Fig.3.27).. 
 
 
 
Fig.3.28. Absorbance profile at 280 nm: G200 chromatography of AtSte 14 in LDAO 0.06%. 
 
The his-tag was not removed and the sample was concentrated using a centrifugal 
concentrator (cut off 10 KDa) to be injected onto a Superdex 200 pre-equilibrated 
with DB. The SEC profile shown in Fig.3.28 suggests that the protein is stable 
and monodisperse in LDAO; the aggregate peak is absent and the protein peak is 
symmetric. 
                                                                      
 
 
Fig.3.29. 15% standard SDS-PAGE: AtSte14 purified sample after concentration to 8 mg/ml. 
M: protein ladder. 
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The fractions containing Ste14 protein were collected and then concentrated to 8 
mg/ml using a centrifugal concentrator (cut off 30 KDa). To check the purity and 
the quality of the sample, 1 µl was loaded on a SDS-PAGE (see Fig.3.29). The 
protein sample seemed to be sufficiently pure to proceed with structural analysis.  
 
B.3.1.2.3. Crystallization trials of AtSte14 
 
Several crystallization trials were prepared at the concentration of 8 mg/ml in 
presence or in absence of ligands. Two batches of the holo-enzyme were obtained 
by adding either 2 mM S-(5′-adenosyl)-L-methionine chloride (SIGMA) or 2 mM 
N-acetyl-S-farnesyl-L-cysteine (Cayman chemical),, a selective inhibitor of  
isoprenylated protein methyltransferases. Up to now no crystals were obtained in 
these trials. 
 
B.3.1.3. Stearoyl-CoA 9-desaturase  
 
B.3.1.3.1. Cloning and expression of human SCD in SF9 insect cells 
 
Due to the problems encountered in the large quantity expression of full-lenght 
hSCD in several prokaryotic and eukaryotic hosts (E.coli, P.pastoris, 
S.cerevisiae), the BaculoDirect™Baculovirus Expression System was utilized to 
obtain hSCD protein from Sf9 insect cells.  
According to the published hSCD sequence (the complete cDNA sequence, 
IMAGE ID 3844850, was obtained from RZPD, Deutsches Ressourcenzentrum 
fuer Genomforschung GmbH), primers were designed to amplify full-length SCD 
cDNA using as a template the plasmid pOTB7.  
The following forward primer incorporates the recombination sequence (in green) 
and the Kozak sequence (in red); the coding sequence is shown in bold: 
 
SCDbac-for: 5’- CACCGGTACCGAAATGCCGGCCCACTTGCTGCAG - 3’ 
 
GGTACC: KpnI restriction site 
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The following reverse primer adds the thrombin cleavage site (in pink). This 
could be used to remove the his-tag that is introduced on the C-terminal cloning 
into the linear baculovirus DNA. 
 
SCDbac-rev: 5’- AATAATAAGCTTGGAACCACGCGGAACCAGGTTTCCA 
TCTCCGGTTCT - 3’ 
 
AAGCTT: HindIII restriction site 
 
Template DNA and primers were subjected to program A (see appendix paragraph 
3) using PFU enzyme. PCR reactions were extracted from agarose gels using the 
GenElute™Gel Extraction Kit (Sigma). The resultant PCR product was cloned 
into pENTR-D-TOPO (see 2.2.3); XL1Blue cells were transformed using the 
reaction and positive colonies were selected by colony PCR (see appendix 
paragraph 3, program C). The constructs obtained were confirmed by restriction 
digestion and DNA sequencing. By LB reaction using LR clonase II, the SCD 
sequence was inserted into linear baculovirus DNA. The recombinant baculovirus 
containing the SCD sequence was confirmed by PCR.  
 
                                                    
 
 
Fig.3.30. Western blot analysis: samples harvested after 96 hours of infection with 1) 15 µl 
V2, 2) 7 µl V2 and 3) 3 µl V2. T: total fraction, before centrifugation; M: protein ladder. 
 
To generate recombinant baculovirus particles, 8x105 Sf9 cells were transfected 
with the LB recombination reaction (see 2.3.4). V0 and V1 viral stocks were 
prepared; different quantities of V1 were tested infecting 1x106 Sf9 and High Five 
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cells seeded in a 6-well plate in 2 ml/well of medium. After 96 hours of infection 
cells were harvested and suspended for one hour in mild agitation in PBS 1X and 
1% DDM. The suspended material was centrifuged at the maximum speed for one 
hour at 4°C. Samples were analyzed by SDS-PAGE and Western blot before and 
after centrifugation. The protein was expressed by both cell lines but only in the 
Sf9 cells the protein was present in the soluble fraction (data not shown). 
Therefore the V1 viral stock was used to generate a large-scale, high-titer viral 
stock (V2 viral stock) for expression studies in Sf9 cells. Different quantities of 
V2 were tested as described previously, the solubilized material was loaded on a 
gel after centrifigation and the protein of interest was detected by Western blot 
analysis (see Fig.3.30). 
 
B.3.1.3.2. Large-scale expression and purification of human SCD 
 
To obtain an adequate amount of pure hSCD, a 300 ml-culture was prepared; Sf9 
cells in mid-log phase in suspension culture were infected with recombinant 
baculovirus (3 µl of V2/1x106 cells) and incubated in a 100 rpm orbital shaker at 
27°C for 96 hours. Infected cells were harvested by centrifugation, cell pellets 
were resuspended in 30 ml of PBS 1X, 1% DDM and 50 µM Fe2+ solution 
(Fe(NH3)2(SO4)2 dissolved in 10-fold molar excess of ascorbate in degassed 60 
mM Hepes pH 7.4)(Goren and Fox, 2008). The sample was left for 1 hour in mild 
agitation at 4°C. The soluble fraction was obtained by centrifugation at 100000g 
for 45 minutes.  
 
 
 
Fig.3.31. Determining the monodispersity of hSCD-GFP fusion in DDM (red) and LDAO 
(black) using FSEC. 
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The best solubilizing detergent was previously identified in small scale 
purification trials with the GFP-fusion protein in S. cerevisiae: the hSCD 
sequence was cloned in pDDGFP-2 and overexpressed. As suggested by FSEC, 
only the DDM solubilized protein seems to be monodisperse (see Fig.3.31). 
Detergent-solubilized hSCD was purified to homogeneity using IMAC; the 
sample was loaded on a column filled with 1 ml of the resin Ni Sepharose 6 Fast 
Flow in the presence of 10 mM imidazole. The column was then washed with EB 
with the addition of 60 mM imidazole and the protein was eluted in 300 mM 
imidazole (see Fig.3.32A). At the same time the protein identity was confirmed by 
Western blot analysis (see Fig.3.32B). 
 
                                      
                                   
 
Fig.3.32. Samples collected during IMAC: A) 12% standard SDS-PAGE and B) Western blot 
analysis. 1) Flow through with 10 mM imidazole, washing with 2) 60 mM imidazole and  3) 
300 mM imidazole. M: protein ladder. 
 
The his-tag was not removed and the sample was concentrated using a centrifugal 
concentrator (cut off 50 KDa). Initial crystal trials were set but up to now no 
crystals were obtained. 
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B.3.1.Discussion 
 
B.3.1.1. GFP-based optimization scheme for the overexpression and 
purification of eukaryotic membrane proteins in S.cerevisiae 
 
One way to improve the chances of success in obtaining pure membrane proteins 
for biochemical and structural analysis is to use GFP-based fusion technology 
(Newstead et al., 2007; Drew et al., 2008). As the C-terminal GFP folds and 
becomes fluorescent only if the upstream membrane protein integrates into the 
membrane, the resultant fluorescence is a fast and accurate measure of membrane-
integrated expression. Fluorescence is easy to measure directly in liquid culture, 
standard SDS-gels and detergent-solubilized membranes. Detergent-solubilized 
membranes can also be subjected to fluorescence size-exclusion chromatography 
(FSEC) to measure the ‘monodispersity’ of the sample. To date, 96 membrane 
proteins from C.glabrata were cloned into a GFP-fusion vector. After obtaining 
colonies, the expression of one colony from each transformation was tested. 
Analyzing the overexpression levels, 12 clones were selected as the best 
overexpressing targets. These data emphasize the importance of initially screening 
the overexpression potential of many membrane proteins. Modest improvement 
could be obtained for a third of the proteins tested by adding DMSO or His to the 
culture medium. Detergent screening and FSEC analysis was carried out for 12 
membrane proteins. The criterion for monodispersity was that a protein peak 
should be symmetric and is equal to or larger than any ‘free GFP’ or aggregation 
peak(s). There was no correlation between the efficiency of the detergent to 
extract the fusion protein and the quality of the FSEC traces. Seven of twelve 
yeast membrane proteins tested were monodisperse in at least one detergent. 
Considering the expression level, the stability after solubilization and the medical 
relevance the most promising clone, C4, was chosen to scale up the purification. 
 
B.3.1.1.1. Farnesyl cysteine-carboxyl methyltransferase from C.glabrata 
 
The clone C4 (Ste14, farnesyl cysteine-carboxyl methyltransferase) was expressed 
in a large-scale culture (10 l). Isolated membranes were solubilised and Ste14 
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purified with both the detergents tested by FSEC (LDAO and DDM). The two 
purifications gave about the same yield and the same final protein purity (2.5-3 
mg). The SEC profile suggests that the protein is monodisperse in both detergents. 
Although several crystallization trials were set up, no crystals were obtained. In 
the near future, it is planned to improve the purification protocol increasing the 
purity up to >95% and, at the same time, to asses the correct fold and catalytic 
properties of the enzyme  by measuring the in vitro activity (Hrycyna and Clarke, 
1990).  
 
B.3.1.1.2. Farnesyl cysteine-carboxyl methyltransferase from A.thaliana 
 
The Ste14 homologue from A.thaliana (AtSte14A) was also cloned in a plasmid 
for expression in E.coli. The protein is smaller than Ste14 from C.glabrata and 
lacks a 50-amino acid cytoplasmic portion on the N-terminal end. AtSte14 can be 
easily extracted from the membranes in LDAO and the SEC profile suggests that 
the protein is monodisperse. Several crystallization trials were set up in the 
presence of 2 mM S-(5′-adenosyl)-L-methionine chloride (a substrate of the 
enzyme) or 2 mM of the selective inhibitor N-acetyl-S-farnesyl-L-cysteine, but up 
to now no crystals were obtained. This is probably due to a low protein 
concentration (8 mg/ml) in the sample. In collaboration with prof. B. Byrne 
(Imperial College, London), it is now planned to clone the cDNA in the pDDGFP-
2 vector for expression in S.cereviesiae. The availability of a large quantity of 
pure protein will allow to prepare several crystal screenings at different 
concentrations of the apo protein or in presence of different ligands.  
 
B.3.1.2. Stearoyl-CoA 9-desaturase  
 
There is no published protocol for a large-scale expression and purification of 
human SCD. Recently, the functional complex of human stearoyl-CoA desaturase 
was produced using a wheat germ cell-free method but  no reasonable enzyme 
quantity for structural studies was obtained with this system (Goren and Fox, 
2008). Here, the baculovirus expression system was selected as a method for large 
scale production. The protein can be efficiently solubilised from the insect cell 
membranes with DDM. A purification protocol was established starting from 300 
Chapter 3                                                                                                         Results and Discussion 
- 85 - 
ml of insect cell culture. Up to now 0.5 mg of 90% pure protein was obtained 
from 300 ml of culture. We intend to conduct activity studies to verify if the 
enzyme is active and, subsequently, to scale up the protein production for 
structural studies.  
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1. Media compositions 
 
1.1. Escherichia coli growth media 
 
Liquid Luria-Bertani (LB) medium 
1% tryptone 
0.5% yeast extract 
0.5% NaCl 
For plates 1.5% bacteriological agar was added. 
 
1.2. Saccharomyces cerevisiae growth media 
 
Liquid URA medium 
2 g yeast synthetic drop-out medium without Ura 
6.7 g yeast nitrogen base without aminoacid  
2% glucose (for pre-culture) or 0.1% glucose (expression culture) 
For plates 1.5% bacteriological agar and 2% glucose was added. 
 
Liquid YPD medium 
2% tryptone 
1% yeast extract 
2% glucose 
 
1.3. Insect cells growth media  
 
Sf-900 II SFM with the addition of 10% FSB (fetal bovine serum) was used for 
Sf9 cell line. 
 
Express Five® SFM with the addition of 2 mM L-glutamine was used for High 
Five cell line. 
 
To all this media antibiotics and antimycotics mix (penicillin G 10 units/ml, 
streptomycin 10 µg/ml, amphotericin B 0.025 µg/ml) was added before using. 
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2. Buffer compositions 
 
2.1. Agarose gel running buffer 
 
TBE 
45 mM Tris-borate  
1 mM EDTA 
 
2.2. Agarose gel loading buffer (6X) 
 
30% glycerol 
0.25% bromophenol blue 
 
2.3. SDS-PAGE running buffer  
 
25 mM Tris-HCl 
200 mM Glycine  
0.1% (w/v) SDS 
 
2.4. SDS-PAGE loading buffer (4X) 
 
10% glycerol 
 62.5 mM Tris-HCl pH 6.8 
 2% SDS 
0.01 mg/ml bromophenol blue 
0.02 5% β-mercaptoethanol 
 
2.5. In gel-fluorescence loading buffer (2X) 
 
50 mM Tris–HCl (pH 7.6) 
5% glycerol, 5 mM EDTA (pH 8.0) 
0.02% bromophenol blue 
Before use 200 ml of 20% SDS and 100 ml of 0.5M DTT was added.  
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2.6. SDS-PAGE staining solution 
 
10% (v/v) acetic acid 
0.1% (w/v) Coomassie Blue dye 
40% (v/v) ethanol 
 
2.7. SDS-PAGE destaining solution 
 
10% (v/v) acetic acid 
10% isopropanol 
 
2.8. Western blotting transfer buffer 
 
25 mM Tris-HCl 
192 mM Glycine 
10% Methanol 
 
2.9. Soluble proteins purification 
 
CRB (1) 
20 mM Tris-HCl pH 7.5 
500 mM NaCl 
 
TBS 
20 mM Tris-HCl pH 7.5 
150 mM NaCl 
 
2.10. Membrane proteins purification 
 
CRB (2) 
50 mM Tris-HCl pH 7.5 
1 mM EDTA 
0.6 M sorbitol 
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EB 
1X PBS 
150 mM NaCl 
10% glycerol 
3x CMC detergent of choice 
 
MRB  
20 mM Tris-HCl pH 7.5 
0.3 M sucrose 
 
DB 
20 mM Tris-HCl pH 7.5 
150 mM NaCl 
3x CMC detergent of choice 
 
PBS 
137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4  
2 mM KH2PO4  
The pH is adjusted to 7.5. 
 
3. PCR programs 
 
A. Sequence amplification from cDNA 
 
Plasmidic DNA (5-50 ng) 
Primer FOR (25µM) 
Primer REV (25µM) 
dNTPs (2.5mM) 
Buffer Taq Polimerase (with MgCl2) 
High Fidelity Taq Polimerase (2-5 units) 
 
Step Temperature Time 
Initial denaturation 95°C 10 minutes 
Amplification (35 cycles) 95°C (denaturation)   1 minute 
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 It depends on primer Tm 
(annealing) 
  1 minute 
 72°C (extension) It depends on sequence 
length and polymerase speed 
Final extension 72°C 10 minutes 
 
B. Site-directed mutagenesis 
 
Point mutations were introduced by PCR using the QuikChange™ site-directed 
mutagenesis kit (Stratagene). 
Plasmidic DNA (5-50 ng) 
Primer FOR (25µM) 
Primer REV (25µM) 
dNTPs (2.5 mM) 
Buffer PFU (with MgCl2) 
PFU (2-5 units) 
 
Step Temperature Time 
Initial denaturation 95°C   1 minute 
Amplification (18 cycles) 95°C (denaturation)   1 minute 
 55°C (annealing)   1 minute 
 68°C (extension) It depends on sequence 
length (plasmid and protein 
sequence) and polymerase 
speed 
Final extension 68°C 10 minutes 
 
C. Colony PCR 
 
Bacterial colony diluted in water  
Primer FOR (25µM) 
Primer REV (25µM) 
dNTPs (2.5 mM) 
Buffer Home made TAQ polymerase (with MgCl2) 
Home made TAQ polymerase (2-5 units) 
 
Step Temperature Time 
Initial denaturation 95°C 10 minutes 
Amplification (30 cycles) 95°C (denaturation)   1 minute 
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 55°C (annealing)   1 minute 
 72°C (extension) It depends on sequence 
length and polymerase speed 
Final extension 72°C 10 minutes 
 
4. Standard SDS-PAGE compositions 
 
Running gel  
 
 12% acrylamide 15% acrylamide 
H20 1.32 ml 0.92 ml 
30% acrylamide mix 1.6 ml 2 ml 
1.5 M Tris pH 8.8  1 ml 1 ml 
10% SDS 0.04 ml 0.04 ml 
10% APS 0.04 ml 0.04 ml 
TEMED  0.004 ml 0.004 ml 
 
Stacking gel  
 
 5% acrylamide 
H20 1.4 ml 
30% acrylamide mix 0.33 ml 
1 M Tris pH 6.8 0.25 ml 
10% SDS 0.02 ml 
10% APS 0.02 ml 
TEMED  0.002 ml 
 
5. Sequences 
 
5.1. Bile acid coenzyme A:amino acid N-acyltransferase  
 
5.1.1. Human BAAT cDNA sequence  
 
ATGATCCAGTTGACAGCTACCCCTGTGAGTGCACTTGTTGATGAGCCAGTGCATA
TCCAAGCTACAGGCCTGATTCCCTTTCAGATGGTGAGTTTTCAGGCATCACTGGA
AGATGAAAACGGAGACATGTTTTATTCTCAAGCCCACTATAGGGCCAATGAATTC
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GGTGAGGTGGACCTGAATCATGCTTCTTCACTTGGAGGGGATTATATGGGAGTCC
ACCCCATGGGTCTCTTCTGGTCTCTGAAACCTGAAAAGCTATTAACAAGACTGTT
GAAAAGAGATGTGATGAATAGGCCTTTCCAGGTCCAAGTAAAACTTTATGACTTA
GAGTTAATAGTGAACAATAAAGTTGCCAGTGCTCCAAAGGCCAGCCTGACTTTGG
AGAGGTGGTATGTGGCACCTGGTGTCACACGAATTAAGGTTCGAGAAGGCCGCCT
TCGAGGAGCTCTCTTTCTCCCTCCAGGAGAGGGTCTCTTCCCAGGGGTAATTGAT
TTGTTTGGTGGTTTGGGTGGGCTGCTTGAATTTCGGGCCAGCCTCCTAGCCAGTC
GTGGCTTCGCCTCCTTGGCCTTGGCTTACCATAACTATGAAGACCTGCCCCGCAA
ACCAGAAGTAACAGATTTGGAATATTTTGAGGAGGCTGCCAACTTTCTCCTGAGA
CATCCAAAGGTCTTTGGCTCAGGCGTTGGGGTAGTCTCTGTATGTCAAGGAGTAC
AGATTGGACTATCTATGGCTATTTACCTAAAGCAAGTCACAGCCACGGTACTTAT
TAATGGGACCAACTTTCCTTTTGGCATTCCACAGGTATATCATGGTCAGATCCAT
CAGCCCCTTCCCCATTCTGCACAATTAATATCCACCAATGCCTTGGGGTTACTAG
AGCTCTATCGCACTTTTGAGACAACTCAAGTTGGGGCCAGTCAATATTTGTTTCC
TATTGAAGAGGCCCAGGGGCAATTCCTCTTCATTGTAGGAGAAGGTGATAAGACT
ATCAACAGCAAAGCACACGCTGAACAAGCCATAGGACAGCTGAAGAGACATGGGA
AGAACAACTGGACCCTGCTATCTTACCCTGGGGCAGGCCACCTGATAGAACCTCC
CTATTCTCCTCTGTGCTGTGCCTCAACGACCCACGATTTGAGGTTACACTGGGGA
GGAGAGGTGATCCCACACGCAGCTGCACAGGAACATGCTTGGAAGGAGATCCAGA
GATTTCTCAGGAAGCACCTCATTCCAGATGTGACCAGTCAACTCTAA 
 
5.1.2. Human BAAT protein sequence 
 
MIQLTATPVSALVDEPVHIQATGLIPFQMVSFQASLEDENGDMFYSQAHYRANEF
GEVDLNHASSLGGDYMGVHPMGLFWSLKPEKLLTRLLKRDVMNRPFQVQVKLYDL
ELIVNNKVASAPKASLTLERWYVAPGVTRIKVREGRLRGALFLPPGEGLFPGVID
LFGGLGGLLEFRASLLASRGFASLALAYHNYEDLPRKPEVTDLEYFEEAANFLLR
HPKVFGSGVGVVSVCQGVQIGLSMAIYLKQVTATVLINGTNFPFGIPQVYHGQIH
QPLPHSAQLISTNALGLLELYRTFETTQVGASQYLFPIEEAQGQFLFIVGEGDKT
INSKAHAEQAIGQLKRHGKNNWTLLSYPGAGHLIEPPYSPLCCASTTHDLRLHWG
GEVIPHAAAQEHAWKEIQRFLRKHLIPDVTSQL 
 
Number of amino acids: 418 
Molecular weight: 46271 Da 
 
5.1.3. Human BAAT protein sequence in pET15 
 
 
MGSSHHHHHHSSGLVPRGSHMIQLTATPVSALVDEPVHIQATGLIPFQMVSFQAS
LEDENGDMFYSQAHYRANEFGEVDLNHASSLGGDYMGVHPMGLFWSLKPEKLLTR
LLKRDVMNRPFQVQVKLYDLELIVNNKVASAPKASLTLERWYVAPGVTRIKVREG
RLRGALFLPPGEGLFPGVIDLFGGLGGLLEFRASLLASRGFASLALAYHNYEDLP
RKPEVTDLEYFEEAANFLLRHPKVFGSGVGVVSVCQGVQIGLSMAIYLKQVTATV
LINGTNFPFGIPQVYHGQIHQPLPHSAQLISTNALGLLELYRTFETTQVGASQYL
FPIEEAQGQFLFIVGEGDKTINSKAHAEQAIGQLKRHGKNNWTLLSYPGAGHLIE
PPYSPLCCASTTHDLRLHWGGEVIPHAAAQEHAWKEIQRFLRKHLIPDVTSQL 
 
Thrombin cleavage site 
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Number of amino acids (__): 421 
Molecular weight (__): 46552.4 
 
C = cysteines 
CDH = catalytic triade 
SQL = peroxisome sorting signal 
 
5.2. Farnesyl cysteine-carboxyl methyltransferase  
 
5.2.1.Ste14 cDNA sequence from C.glabrata  
 
ATGACTGGATCAAACAAATCTGAGAAATTTGTGCCTGATGCGGAAGGCCTGCCTG
TAATAATAAATGGTAAAGCATACCCAGACATTCGTCGCAATCCATTAGATGACAT
TGCTGTAACCTCATTTGCACTGGGAATCCTTCTCGGTATATTCGTTGGTCTCCTT
ACATTCACACAGTTCAGAAATTTCAATGTTTATATCATTGCCCTGTCAATATTCC
ATTTCCTTGAGTTTTATGTAACTGCCAAGGTGAACCCAGGTAAAGTCAACTCAGA
CTCCTTCCTTTTGAACAATGGTATCGGTTATCTTGGTGCACACATGTTCGGTGTC
CTTGAGTGTCTTGTGGAAAGTATATTCTTTCCTAATATGAAGAAGATTAGCAACT
CTTGGGTAGCAATATTCTTAACAATCATCGGGGTAATATTGATACTTTTAGGTCA
AGTGTCTAGATCAATGGCCATGTATCAAGCTGGTAAGTCATTCTCTCATATCTTG
AAGACGGAGAAACTCGACGATCACACATTAGTGACCACAGGCATTTATGGATATT
TGAGGCATCCAAGTTATTTTGGTTTTTTCTGGTGGGCTATAGGGACTCAATTGCT
ACTCTTAAATCCAATTGCATTGATTGTCTTTGTAGGCGTGCTTTGGAGCTTCTTT
AATAAGCGCATATTAATTGAGGAGAAATACCTTATACAGTTCTTTGGTGAGCAGT
ACATAAACTACAAAAAAAGGGTCAAGGTATGGATACCGTTAATTGATTAG 
 
5.2.2. Ste14 protein sequence from C.glabrata 
 
MTGSNKSEKFVPDAEGLPVIINGKAYPDIRRNPLDDIAVTSFALGILLGIFVGLL
TFTQFRNFNVYIIALSIFHFLEFYVTAKVNPGKVNSDSFLLNNGIGYLGAHMFGV
LECLVESIFFPNMKKISNSWVAIFLTIIGVILILLGQVSRSMAMYQAGKSFSHIL
KTEKLDDHTLVTTGIYGYLRHPSYFGFFWWAIGTQLLLLNPIALIVFVGVLWSFF
NKRILIEEKYLIQFFGEQYINYKKRVKVWIPLID 
 
Number of amino acids: 254 
Molecular weight: 28885 Da 
 
5.2.3. Ste14 protein sequence from C.glabrata in pDDGFP-2 
 
MTGSNKSEKFVPDAEGLPVIINGKAYPDIRRNPLDDIAVTSFALGILLGIFVGLL
TFTQFRNFNVYIIALSIFHFLEFYVTAKVNPGKVNSDSFLLNNGIGYLGAHMFGV
LECLVESIFFPNMKKISNSWVAIFLTIIGVILILLGQVSRSMAMYQAGKSFSHIL
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KTEKLDDHTLVTTGIYGYLRHPSYFGFFWWAIGTQLLLLNPIALIVFVGVLWSFF
NKRILIEEKYLIQFFGEQYINYKKRVKVWIPLIDGENLYFQGQPSKGEE... 
 
 
Number of amino acids (__): 261 
Molecular weight (__): 29737 Da 
 
C = cysteine 
SKGEE… = GFP sequence 
 
5.2.4. Ste14 cDNA sequence from A.thaliana  
 
ATGACAGAGATCTTCAGTGACACCAGCATCAGACAGTTATCTCAAATGCTACTAT
CACTAATCTTCTTCCACATATCCGAATACATTCTAGCCATCACCATTCACGGAGC
ATCAAACGTAACTCTTAGTTCGCTTTTAATCACCAAGCATTACGCTTTAGCAATG
CTTCTGTCGCTTCTCGAATACCTAACGGAGATTATCCTCTTCCCGGGGCTGAAAC
AACACTGGTGGGTCAGCAACTTTGGACTCATAATGATCATCGTTGGGGAAATCAT
CAGGAAGGCAGCGATAATAACAGCGGGAAGATCGTTCACTCACCTCATAAAGATC
AACTACGAAGAGCATCACGGGCTTGTGACTCATGGTGTGTATAGACTAATGAGGC
ATCCAAGTTACTGCGGTTTTCTCATCTGGTCGGTCGGGACACAAGTTATGCTCTG
TAACCCCGTTTCAGCAGTTGCGTTCGCGGTTGTCGTGTGGCGGTTTTTTGCTCAG
AGAATACCGTACGAGGAGTATTTTCTGAATCAGTTTTTTGGGGTACAGTATCTAG
AGTATGCAGAGAGTGTTGCCTCTGGTGTTCCATTTGTGAACTGA 
 
5.2.5. Ste14 protein sequence from A.thaliana 
 
MTEIFSDTSIRQLSQMLLSLIFFHISEYILAITIHGASNVTLSSLLITKHYALAM
LLSLLEYLTEIILFPGLKQHWWVSNFGLIMIIVGEIIRKAAIITAGRSFTHLIKI
NYEEHHGLVTHGVYRLMRHPSYCGFLIWSVGTQVMLCNPVSAVAFAVVVWRFFAQ
RIPYEEYFLNQFFGVQYLEYAESVASGVPFVN 
 
Number of amino acids: 197 
Molecular weight: 22525 Da 
 
5.2.6. Ste14 protein sequence from A.thaliana in pET15 
 
MGSSHHHHHHSSGLVPRGSHMTEIFSDTSIRQLSQMLLSLIFFHISEYILAITIH
GASNVTLSSLLITKHYALAMLLSLLEYLTEIILFPGLKQHWWVSNFGLIMIIVGE
IIRKAAIITAGRSFTHLIKINYEEHHGLVTHGVYRLMRHPSYCGFLIWSVGTQVM
LCNPVSAVAFAVVVWRFFAQRIPYEEYFLNQFFGVQYLEYAESVASGVPFVN 
 
Number of amino acids: 217 
Molecular weight: 24688 Da 
 TEV cleavage site 
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LVPRGS = thrombin cleavage site 
 
5.2.7. Sequences alignment of human Icmt, AtSte14 and yeast Ste14  
 
 
 
 
5.3. Stearoyl-CoA 9-desaturase  
 
5.3.1. Human SCD cDNA sequence  
 
ATGCCGGCCCACTTGCTGCAGGACGATATCTCTAGCTCCTATACCACCACCACCA
CCATTACAGCGCCTCCCTCCAGGGTCCTGCAGAATGGAGGAGATAAGTTGGAGAC
GATGCCCCTCTACTTGGAAGACGACATTCGCCCTGATATAAAAGATGATATATAT
GACCCCACCTACAAGGATAAGGAAGGCCCAAGCCCCAAGGTTGAATATGTCTGGA
GAAACATCATCCTTATGTCTCTGCTACACTTGGGAGCCCTGTATGGGATCACTTT
GATTCCTACCTGCAAGTTCTACACCTGGCTTTGGGGGGTATTCTACTATTTTGTC
AGTGCCCTGGGCATAACAGCAGGAGCTCATCGTCTGTGGAGCCACCGCTCTTACA
AAGCTCGGCTGCCCCTACGGCTCTTTCTGATCATTGCCAACACAATGGCATTCCA
GAATGATGTCTATGAATGGGCTCGTGACCACCGTGCCCACCACAAGTTTTCAGAA
ACACATGCTGATCCTCATAATTCCCGACGTGGCTTTTTCTTCTCTCACGTGGGTT
GGCTGCTTGTGCGCAAACACCCAGCTGTCAAAGAGAAGGGGAGTACGCTAGACTT
GTCTGACCTAGAAGCTGAGAAACTGGTGATGTTCCAGAGGAGGTACTACAAACCT
GGCTTGCTGATGATGTGCTTCATCCTGCCCACGCTTGTGCCCTGGTATTTCTGGG
GTGAAACTTTTCAAAACAGTGTGTTCGTTGCCACTTTCTTGCGATATGCTGTGGT
GCTTAATGCCACCTGGCTGGTGAACAGTGCTGCCCACCTCTTCGGATATCGTCCT
TATGACAAGAACATTAGCCCCCGGGAGAATATCCTGGTTTCACTTGGAGCTGTGG
GTGAGGGCTTCCACAACTACCACCACTCCTTTCCCTATGACTACTCTGCCAGTGA
GTACCGCTGGCACATCAACTTCACCACATTCTTCATTGATTGCATGGCCGCCCTC
GGTCTGGCCTATGACCGGAAGAAAGTCTCCAAGGCCGCCATCTTGGCCAGGATTA
AAAGAACCGGAGATGGAAACTAA 
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5.3.2. Human SCD protein sequence 
 
MPAHLLQDDISSSYTTTTTITAPPSRVLQNGGDKLETMPLYLEDDIRPDIKDDIY
DPTYKDKEGPSPKVEYVWRNIILMSLLHLGALYGITLIPTCKFYTWLWGVFYYFV
SALGITAGAHRLWSHRSYKARLPLRLFLIIANTMAFQNDVYEWARDHRAHHKFSE
THADPHNSRRGFFFSHVGWLLVRKHPAVKEKGSTLDLSDLEAEKLVMFQRRYYKP
GLLMMCFILPTLVPWYFWGETFQNSVFVATFLRYAVVLNATWLVNSAAHLFGYRP
YDKNISPRENILVSLGAVGEGFHNYHHSFPYDYSASEYRWHINFTTFFIDCMAAL
GLAYDRKKVSKAAILARIKRTGDGN 
 
Number of amino acids: 355 
Molecular weight: 41087 Da 
 
5.3.3. Human SCD protein sequence in linear baculovirus DNA  
 
MPAHLLQDDISSSYTTTTTITAPPSRVLQNGGDKLETMPLYLEDDIRPDIKDDIY
DPTYKDKEGPSPKVEYVWRNIILMSLLHLGALYGITLIPTCKFYTWLWGVFYYFV
SALGITAGAHRLWSHRSYKARLPLRLFLIIANTMAFQNDVYEWARDHRAHHKFSE
THADPHNSRRGFFFSHVGWLLVRKHPAVKEKGSTLDLSDLEAEKLVMFQRRYYKP
GLLMMCFILPTLVPWYFWGETFQNSVFVATFLRYAVVLNATWLVNSAAHLFGYRP
YDKNISPRENILVSLGAVGEGFHNYHHSFPYDYSASEYRWHINFTTFFIDCMAAL
GLAYDRKKVSKAAILARIKRTGDGNLVPRGSKLIIKGGRADPAFLYKVVRMNEDL
GKPIPNPLLGLDSTRTGHHHHHH 
 
Number of amino acids: 408 
Molecular weight: 46967 Da 
 
LVPRGS = thrombin cleavage site 
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The last five years have seen a dramatic increase in the number of membrane protein structures. 
The vast majority of these 191 unique structures are of membrane proteins from prokaryotic 
sources. Whilst these have provided unprecedented insight into the mechanism of action of these 
important molecules our understanding of many clinically important eukaryotic membrane 
proteins remains limited by a lack of high resolution structural data. It is clear that novel 
approaches are required to facilitate the structural characterization of eukaryotic membrane 
proteins. Here we review some of the techniques developed recently which are having a major 
impact on the way in which structural studies of eukaryotic membrane proteins are being 
approached. Several different high throughput approaches have been designed to identify 
membrane proteins most suitable for structural studies. One approach is to screen large numbers of 
related or non-related membrane proteins using GFP fusion proteins. An alternative involves 
generating large numbers of mutants of a single protein with a view to obtaining a fully functional 
but highly stable membrane protein. These, and other novel techniques that aim to facilitate the 
production of protein likely to yield well-diffracting crystals are described. 
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